Journal of the American College of Cardiology
-
Publication Venue For
-
Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
81:2149-2160.
2023
-
Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation.
81:2161-2171.
2023
-
Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: Strong Impact Across Ejection Fraction Spectrum.
81:2145-2148.
2023
-
RESPONSE: The CardioNerds Clinical Trial Network: A Model for Inspiring the Next Generation of Trialists
2023
-
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
80:e223-e393.
2022
-
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
79:e21-e129.
2022
-
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
79:197-215.
2022
-
TCT-269 Five-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement: Excellent Valve-Specific Outcomes but Poor Overall Survival.
78:B110-B110.
2021
-
A Good Start to Lowering BP and CVD Risk in Sub-Saharan Africa..
77:2019-2021.
2021
-
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
77:e25-e197.
2021
-
Pre-Pregnancy Hypertension Among Women in Rural and Urban Areas of the United States..
76:2611-2619.
2020
-
In Memoriam: James T. Willerson, 1939 to 2020.
76:2173-2174.
2020
-
Surgical Aortic Valve Replacement for Failed TAVR Prostheses: One More Piece of the Puzzle..
76:1860-1861.
2020
-
BYSTANDER PERFORMANCE DURING SIMULATED DRONE DELIVERY OF AN AED FOR MOCK OUT-OF-HOSPITAL CARDIAC ARREST.
75:303-303.
2020
-
Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent-A Post Hoc Analysis From the EVOLVE Short DAPT Study.
76:B164-B164.
2020
-
TCT-406 Clinical Impact of DAPT Cessation Within 12 Months of Drug-Eluting Stent Implantation in Caucasians and Minorities: Insights From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study.
74:B402-B402.
2019
-
2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards) and the American Society of Echocardiography.
74:403-469.
2019
-
Rivaroxaban Plus Aspirin After CABG: More Evidence Is Needed..
73:2359-2360.
2019
-
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society (vol 72, pg 1677, 2018).
72:1760-1760.
2018
-
Correction.
72:1756-1759.
2018
-
Familial Chylomicronemia Syndrome.
72:1177-1179.
2018
-
Cardiovascular Outcomes Reported in Hemodialysis Trials..
71:2802-2810.
2018
-
Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block (vol 71, pg 306, 2018).
71:1296-1296.
2018
-
Antithrombotic Therapy in Peripheral Artery Disease Generating and Translating Evidence Into Practice.
71:353-362.
2018
-
RESPONSE: Enabling the Learning Health System, One FIT at a Time.
70:2454-2454.
2017
-
RESPONSE: Training in Precision Cardiology The Time Is Now.
70:1678-1679.
2017
-
Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering..
70:766-775.
2017
-
Palliative Care in Heart Failure The PAL-HF Randomized, Controlled Clinical Trial.
70:332-341.
2017
-
Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial (vol 69, pg 1577, 2017).
69:2355-2355.
2017
-
Correction.
69:1520-1520.
2017
-
Correction.
69:1102-1102.
2017
-
Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry..
69:265-274.
2017
-
Correction.
68:2922-2923.
2016
-
Correction.
68:2924-2925.
2016
-
RESPONSE: Justified Optimism or Magical Thinking?.
67:3018-3019.
2016
-
Erratum: Variables Measured during Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure (Journal of the American College of Cardiology (2016) 67 (780-789)).
67:1979.
2016
-
Erratum: 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards) (J Am Coll Cardiol 66 (403-469)).
66.
2015
-
RESPONSE: Look Inward First.
66:974-975.
2015
-
Erratum: Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from Peripheral Academic Research Consortium (PARC) (Journal of the American College of Cardiology (2015) 65:(931-41)).
65:2578-2579.
2015
-
ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3): A Report of the ACC Competency Management Committee.
65:1721-1723.
2015
-
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: Executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines.
64:2373-2405.
2014
-
Notice.
64:2438-2438.
2014
-
Erratum: Update on the American Board of Internal Medicine Maintenance of Certification Program: A Report of the American College of Cardiologys Educational Quality Review Board (Journal of the American College of Cardiology (2014) 63 (92-100)).
63:2887-2888.
2014
-
Erratum: ACC/AHA/SCAI/AMAConvened PCPI/ NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention (Journal of the American College of Cardiology (2014) 63 (722-745) doi:10.1016/j.jacc.2013.12.003).
63:1590-1591.
2014
-
CIRCULATING SURFACTANT PROTEINS, DYSPNEA, AND MARKERS OF CONGESTION IN ACUTE DECOMPENSATED HEART FAILURE: REPORT FROM THE DIURETIC OPTIMIZATION STRATEGIES EVALUATION (DOSE) STUDY.
63:A919-A919.
2014
-
DUAL ANTIPLATELET THERAPY AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROMES.
63:A103-A103.
2014
-
ECHOCARDIOGRAPHIC FINDINGS PREDICT IN-HOSPITAL AND 1-YEAR MORTALITY IN LEFT-SIDED NATIVE VALVE STAPHYLOCOCCUS AUREUS ENDOCARDITIS: AN ANALYSIS FROM THE INTERNATIONAL COLLABORATION ON ENDOCARDITIS- PROSPECTIVE ECHO COHORT STUDY.
63:A974-A974.
2014
-
GLOBAL LONGITUDINAL STRAIN AS A PREDICTOR OF SUDDEN CARDIAC DEATH AND DEATH FROM OTHER CAUSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION.
63:A1129-A1129.
2014
-
GLOBAL LONGITUDINAL STRAIN BECOMES IMPAIRED IN CHEMOTHERAPY TREATED BREAST CANCER PATIENTS.
63:A1135-A1135.
2014
-
GLOBAL LONGITUDINAL STRAIN IS SUBSTANTIALLY IMPAIRED IN HOSPITALIZED ACUTE HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION.
63:A554-A554.
2014
-
HIGH DEGREE ATRIOVENTRICULAR BLOCK, ASYSTOLE, AND ELECTRO-MECHANICAL DISSOCIATION COMPLICATING NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION.
63:A411-A411.
2014
-
HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION RESULTS IN SUBSTANTIAL REVERSE REMODELING OF THE LEFT VENTRICLE IN ISCHEMIC CARDIOMYOPATHY.
63:A1572-A1572.
2014
-
IMPORTANCE OF AORTIC STENOSIS IN PATIENTS PRESENTING WITH ACUTE MYOCARDIAL INFARCTION.
63:A123-A123.
2014
-
INDIVIDUAL PROTON PUMP INHIBITORS AND OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE ON DUAL ANTIPLATELET THERAPY.
63:A203-A203.
2014
-
LEFT BUNDLE BRANCH BLOCK IS NOT INDEPENDENTLY ASSOCIATED WITH LONG TERM MORTALITY AMONG PATIENTS WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION.
63:A343-A343.
2014
-
OMICS PROFILING HIGHLIGHTS ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION AND UBIQUITIN PROTEASOME PATHWAYS IN INSULIN RESISTANCE AND GLYCEMIC CONTROL.
63:A1600-A1600.
2014
-
PROGRESSION OF SIGNIFICANT FUNCTIONAL MR IN MEDICALLY MANAGED PATIENTS.
63:A2007-A2007.
2014
-
SERIAL CHANGES IN MYOCARDIAL STRAIN IN MEDICALLY MANAGED SEVERE AORTIC STENOSIS AND LONG TERM OUTCOMES.
63:A2022-A2022.
2014
-
SHORTER HOSPITAL STAYS AND OUTCOMES AFTER NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION.
63:A42-A42.
2014
-
TICAGRELOR PLASMA LEVELS BUT NOT CLINICAL OUTCOMES ARE ASSOCIATED WITH TRANSPORTER AND METABOLISM ENZYME GENETIC POLYMORPHISMS.
63:A25-A25.
2014
-
Heart Failure With Preserved Ejection Fraction.
63:457-459.
2014
-
Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: A report from the NCDR (National Cardiovascular Data Registry).
63:788-796.
2014
-
INCIDENCE AND PREDICTORS OF SUDDEN CARDIAC DEATH AFTER HOSPITALIZATION FOR NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: AN ANALYSIS FROM THE TRACER TRIAL.
61:E109-E109.
2013
-
Erratum: A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the united states: A report from the cathpci registry of the national cardiovascular data registry, 2010 through june 2011 (Journal of the American College of Cardiology (2012) 60 (2017-31)).
60:2605-2606.
2012
-
Erratum: Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registrys ICD registry (Journal of the American College of Cardiology (2012) 60(1577-80)).
60:2605.
2012
-
Reply.
60:2425-2426.
2012
-
Reply.
60:1713-1714.
2012
-
Erratum: Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: A report from the national cardiovascular data registry, 2004 to 2008 (Journal of the American College of Cardiology (2012) 59 (648654)).
59:1493-1494.
2012
-
Erratum: ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: A report of the American College of Cardiology Foundation appropriate use criteria task force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association.
59:1336.
2012
-
INTRAMYOCARDIAL STEM CELL INJECTION CAN REVERSE THE LEFT VENTRICULAR SPHERICAL REMODELING OF ISCHEMIC CARDIOMYOPATHY: TURNING SOCCER BALLS INTO (AMERICAN) FOOTBALLS.
59:E921-E921.
2012
-
PREDICTORS OF PULMONARY ARTERIAL HYPERTENSION IN ATRIAL SEPTAL DEFECT PATIENTS.
59:E2117-E2117.
2012
-
TEMPORAL TRENDS IN PERCUTANEOUS CORONARY INTERVENTION OUTCOMES AMONG OLDER PATIENTS.
59:E73-E73.
2012
-
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary.
58:2584-2614.
2011
-
Reply.
58:776-777.
2011
-
BETA-ARRESTINS REGULATE SIGNALING BY BONE MORPHOGENETIC PROTEIN TYPE II RECEPTOR IN PULMONARY ARTERIAL HYPERTENSION.
57:E2046-E2046.
2011
-
WHAT THRESHOLD SHOULD BE USED TO DEFINE PERCUTANEOUS CORONARY INTERVENTION-RELATED MYOCARDIAL INFARCTION? AN APPROACH BASED ON CLINICAL RELEVANCE FROM EARLY ACS AND SYNERGY.
57:E1239-E1239.
2011
-
EVEREST II Randomized Clinical Trial: Clinical Benefit by MR Grade in Patients One Year following Successful MitraClip Therapy.
56:B25-B25.
2010
-
EVEREST II Randomized Clinical Trial: Significant Reverse Left Ventricular Remodeling One Year following MV Surgery and MitraClip Therapy.
56:B24-B24.
2010
-
Correction.
55:2185-2185.
2010
-
Reply.
55:1052-1053.
2010
-
DOWNSTREAM CORONARY EFFECTS OF DRUG ELUTING STENTS: UNINTENDED THERAPEUTIC TARGET?.
55:A171.E1604-A171.E1604.
2010
-
RED GINSENG EXTRACTS IMPROVED CORONARY FLOW RESERVE AND INCREASED ABSOLUTE NUMBERS OF VARIOUS CIRCULATING ANGIOGENIC CELLS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION.
55:A100.E936-A100.E936.
2010
-
VASODILATOR RESPONSE PREDICTS LONG-TERM SURVIVAL IN PULMONARY HYPERTENSION REGARDLESS OF ETIOLOGY.
55:A154.E1447-A154.E1447.
2010
-
Reply.
55:268-269.
2010
-
Reply.
55:1884-.
2010
-
Reply.
55:81.
2009
-
A Clinical Risk Prediction Tool for Post-PCI Bleeding From the National Cardiovascular Data Registry (R) (NCDR (R)).
53:A23-A23.
2009
-
A Multivariable Model From HF-ACTION Predicting Peak VO2 in a Heart Failure Population.
53:A301-A301.
2009
-
A Simple and Effective Approach to Improving Cardiac Rehabilitation (CR) Referrals: Improving Clinical Practice Through Mandatory Computerized Physician Order Entry (CPOE).
53:A225-A225.
2009
-
Age-Related Incidence of Asymptomatic Patent Foramen Ovale in 13,261 Patients Undergoing Cardiothoracic Surgery.
53:A362-A362.
2009
-
Annual Case Volume Is Not a Strong Predictor of Bleeding Complications After Percutaneous Coronary Intervention: A Report From the National Cardiovascular Data Registry.
53:A373-A373.
2009
-
Antithrombotic Strategy During Percutaneous Coronary Iintervention in NSTEMI: Update From ACTION Registry-GWTG.
53:A398-A398.
2009
-
Biomarker Guided Therapy in Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
53:A155-A155.
2009
-
Clopidogrel Use and Clinical Events After Drug-Eluting Stent Implantation: Findings From the HealthCore Integrated Research Database.
53:A11-A12.
2009
-
Identifying Patients at Risk for Reoperation for Bleeding After Coronary Artery Bypass Surgery.
53:A334-A334.
2009
-
Influence of Transfer-In Rates on Quality of Care and Outcomes at Receiving Hospitals in Patients With Non-ST-Elevation Acute Coronary Syndromes.
53:A367-A367.
2009
-
Left Bundle Branch Block Without Concordant ST-Elevation In Suspected ST-Elevation Myocardial Infarction Identifies Patients With High False Positive Rates: Insights From the APEX-AMI Trial.
53:A323-A323.
2009
-
Limitations of Using Cardiac Catheterization Rates as a Quality Measure for Non ST-Segment Elevation Myocardial Infarction.
53:A370-A370.
2009
-
Long-Term Outcomes of Drug-Eluting Versus Bare-Metal Stents in Underrepresented Populations: Results From the Linked NCDR and CMS Database.
53:A386-A386.
2009
-
Midterm Follow-up after Helex Device Closure of Patent Foramen Ovale for Prevention of Paradoxical Embolic Events.
53:A96-A96.
2009
-
Outcomes Following Coronary Stenting in a Linked NCDR and CMS Database: A National Study of Long-Term, Real World Outcomes of Bare Metal and Drug-Eluting Stents.
53:A401-A402.
2009
-
Patterns of Cardiac Stress Testing After Revascularization in Community Practice.
53:A389-A389.
2009
-
Patterns of Septal Hypertrophy in Hypertrophic Cardiomyopathy Are Associated With Differences in Clinical and Functional Characteristics by Echocardiography and Cardiac MRI.
53:A172-A172.
2009
-
Percutaneous Coronary Intervention for Treatment of Symptomatic Ischemic Heart Failure With Normal Left Ventricular Systolic Function.
53:A51-A51.
2009
-
Prognostic Value of Stress Myocardial Perfusion SPECT and the Impact of Body Mass Index on Cardiac Mortality.
53:A290-A290.
2009
-
Quality of Care for Atrial Fibrillation Among Patients Hospitalized for Heart Failure.
53:A162-A162.
2009
-
Racial/Ethnic Differences in the Treatment of Acute Myocardial Infarction: Findings From the Get With the Guidelines CAD Program.
53:A369-A369.
2009
-
Readmission in Patients With Acute Severe Hypertension Is Common and Predictable: The Studying the Treatment of Acute hyperTension Registry.
53:A214-A214.
2009
-
Relationship Between Anemia Status and Health Care Costs in Patients With Symptomatic Heart Failure.
53:A391-A391.
2009
-
Relationship Between NTproBNP and Exercise Capacity in Chronic Heart Failure: Baseline Data from the HF-ACTION Study.
53:A189-A189.
2009
-
Reporting and Representation of Race in Published Randomized Trials.
53:A372-A372.
2009
-
Risk of GUSTO Moderate or Severe Bleeding identified by the CRUSADE Bleeding Model.
53:A384-A384.
2009
-
ST-Elevation Myocardial Infarction Care and Outcomes for the Oldest-Old.
53:A325-A325.
2009
-
Surgical Maze Procedure as a Treatment for Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
53:A118-A118.
2009
-
The Extent of Warfarin Use and its Effectiveness Within Atrial Fibrillation Patients from a US Nationally Representative Sample.
53:A396-A396.
2009
-
The Importance of Clinical Predictors of 30-Day Mortality Among Medicare Beneficiaries.
53:A387-A387.
2009
-
Utilization of Antithrombotic Agents Among Patients Admitted With Myocardial Infarction in the ACTION Registry-GWTG.
53:A324-A325.
2009
-
Variation in Early Death and All-Cause Readmission After a Hospitalization for Heart Failure Among Medicare Beneficiaries.
53:A379-A379.
2009
-
Warfarin Is Independently Associated With Lower Risk of Six-Month Death or Myocardial Infarction in Patients With Atrial Fibrillation Following Acute Coronary Syndromes.
53:A354-A354.
2009
-
What is the optimal PCI strategy (two stents vs. provisional) for coronary artery bifurcation lesions? Meta-analysis of randomized trials.
53:A79-A79.
2009
-
Reply.
54:90-91.
2009
-
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease.
52:1890-1947.
2008
-
Reply.
52:1038.
2008
-
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices).
51:2085-2105.
2008
-
Reply.
51:1235.
2008
-
Predictors of coronary artery calcium progression in a multiethnic cohort of older adults.
51:A154-A154.
2008
-
Reply.
49:1751-1752.
2007
-
Reply.
49:1106-1107.
2007
-
Troponin elevation after percutaneous coronary intervention predicts major cardiac adverse outcomes in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial.
49:22B-22B.
2007
-
Reply.
49:729.
2007
-
President's Page: John C. (Jack) Lewin, MD: From Rural Maui to CEO of the American College of Cardiology.
48:584-585.
2006
-
Reply.
47:2566.
2006
-
An Introduction.
47.
2006
-
Reply [10].
47:471.
2006
-
Erratum: How to become a cardiovascular investigator (Journal of the American College of Cardiology (October 4, 2005) SUPPL. A)).
46:2151-2152.
2005
-
Erratum: The relation between patient's outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating medicare beneficiaries (Journal of the American College of Cardiology (2005) 46 (1536-1540)).
46:1964.
2005
-
The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating medicare beneficiaries (vol 46, pg 1536, 2005).
46:1964-1964.
2005
-
Reply.
46:1376-1377.
2005
-
Impaired endothelial function in coronary heart disease patients with depressive symptomatology..
46:656-659.
2005
-
Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study..
46:457-463.
2005
-
President's page: Education: Drudgery or excitement? You choose.
46:558-559.
2005
-
Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis..
46:497-504.
2005
-
Improving quality of life after cardiogenic shock: do more revascularization!.
46:274-276.
2005
-
Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine)..
46:184-221.
2005
-
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes..
46:29-38.
2005
-
President's page: Reframing debate in patient care image..
46:176-177.
2005
-
Erratum: Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention (Journal of the American College of Cardiology (2005) 45 (369-376)).
45:1912.
2005
-
President's Page: Quality: it's in your hands..
45:1903-1904.
2005
-
Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression..
45:1862-1870.
2005
-
Endothelial progenitor obsolescence and atherosclerotic inflammation..
45:1458-1460.
2005
-
Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging..
45:1494-1504.
2005
-
Further aspects of anemia, heart failure, and erythropoietin..
45:1549-1550.
2005
-
Omega-3 fatty acids for secondary prevention..
45:1552.
2005
-
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score..
45:1397-1405.
2005
-
The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting..
45:1392-1396.
2005
-
Reply.
45:1550-1551.
2005
-
Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial..
45:1172-1179.
2005
-
Surrogates, substudies, and real clinical end points in trials of drug-eluting stents..
45:1206-1212.
2005
-
Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes..
45:1322-1326.
2005
-
Task Force 3: valvular heart disease..
45:1334-1340.
2005
-
Task Force 7: arrhythmias..
45:1354-1363.
2005
-
Afterload reduction in chronic aortic regurgitation: it sure seems like a good idea..
45:1031-1033.
2005
-
Infarct morphology identifies patients with substrate for sustained ventricular tachycardia..
45:1104-1108.
2005
-
Upon convocation: dream big, love big..
45:1142-1143.
2005
-
Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative..
45:832-837.
2005
-
The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology..
45:637-651.
2005
-
Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction..
45:508-514.
2005
-
Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks..
45:471-478.
2005
-
Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention..
45:369-376.
2005
-
Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction..
45:321-323.
2005
-
A time of accelerated change in academic cardiovascular medicine: implications for academic divisions of cardiology and their training programs..
44:1957-1965.
2004
-
Economic impact of new interventional therapies: are we asking the right questions?.
44:1809-1811.
2004
-
Highlights of Heart Rhythm 2004, the Annual Scientific Sessions of the Heart Rhythm Society: May 19 to 22, 2004, in San Francisco, California..
44:1550-1556.
2004
-
Task force 2: Investigator participation in clinical research..
44:1729-1736.
2004
-
Task force 5: Expert testimony and opinions..
44:1747-1749.
2004
-
Task force 6: Code of conduct for staff and volunteer leadership..
44:1750-1753.
2004
-
Outcomes in heart failure patients after major noncardiac surgery..
44:1446-1453.
2004
-
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial..
44:1215-1223.
2004
-
Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI)..
44:766-774.
2004
-
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction)..
44:671-719.
2004
-
Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial..
44:547-553.
2004
-
Depression as a risk factor for post-MI mortality..
44:472.
2004
-
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction..
44:305-312.
2004
-
Valvular disease..
44:7A-9A.
2004
-
Working group 1: How to increase the output of cardiologists..
44:233-237.
2004
-
Working group 8: Defining the different types of cardiovascular specialists and developing a new model for training general clinical cardiologists..
44:267-271.
2004
-
Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy..
44:38-43.
2004
-
Citius, altius, fortius (the Olympic motto: swifter, higher, stronger)..
44:150-151.
2004
-
State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction..
44:192-198.
2004
-
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction..
43:2153-2159.
2004
-
High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST)..
43:2066-2071.
2004
-
Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size..
43:2124-2131.
2004
-
Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction..
43:1780-1787.
2004
-
Depression: are we ignoring an important comorbidity in heart failure?.
43:1550-1552.
2004
-
Predictors of stroke in patients paced for sick sinus syndrome..
43:1617-1622.
2004
-
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial..
43:1534-1541.
2004
-
Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial..
43:1368-1374.
2004
-
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction..
43:1170-1176.
2004
-
For how long should treatment with clopidogrel be continued after coronary stent implantation?.
43:1331.
2004
-
The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial..
43:1211-1216.
2004
-
Reply.
43:1331-1332.
2004
-
Aspirin dose and six-month outcome after an acute coronary syndrome..
43:972-978.
2004
-
Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty..
43:936-942.
2004
-
1163-109 Ongoing myocardial damage in severe heart failure: Prognostic usefulness of cardiac troponin T monitoring to identifying high-risk patients.
43:A226-A226.
2004
-
Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction..
43:549-556.
2004
-
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial..
43:542-548.
2004
-
The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease..
43:576-582.
2004
-
Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators..
43:39-43.
2004
-
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure..
43:61-67.
2004
-
From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes..
42:1611-1616.
2003
-
Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab..
42:1178-1185.
2003
-
Platelet inhibition strategies in percutaneous coronary intervention: competition or coopetition?.
42:1196-1198.
2003
-
The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk..
42:1206-1207.
2003
-
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study..
42:1132-1139.
2003
-
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial..
42:971-977.
2003
-
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist..
42:1098-1102.
2003
-
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)..
42:954-970.
2003
-
Clinical prediction models: are we building better mousetraps?.
42:851-853.
2003
-
Sparing a little may save a lot: lessons from the Studies of Left Ventricular Dysfunction (SOLVD)..
42:709-711.
2003
-
Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease..
42:505-512.
2003
-
Cholesterol emboli after invasive cardiac procedures..
42:217-218.
2003
-
Valvular heart disease..
42:388-390.
2003
-
Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4..
42:45-53.
2003
-
34th Bethesda Conference: Can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease?.
41:1855-1917.
2003
-
34th Bethesda Conference: Task force #5--Is atherosclerosis imaging cost effective?.
41:1906-1917.
2003
-
Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry..
41:1940-1945.
2003
-
Poverty, process of care, and outcome in acute coronary syndromes..
41:1948-1954.
2003
-
Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?.
41:1568-1572.
2003
-
Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4)..
41:1452-1457.
2003
-
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial..
41:1251-1260.
2003
-
Differential gene expression and genomic patient stratification following left ventricular assist device support..
41:1096-1106.
2003
-
Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study..
41:997-1003.
2003
-
Matrix metalloproteinase genetic polymorphisms in premature coronary artery disease.
41:234A-234A.
2003
-
Matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis: Relation with inflammation and metabolic markers.
41:282A-283A.
2003
-
The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: do race and gender matter?.
41:949-954.
2003
-
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy..
41:916-924.
2003
-
ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence..
41:687-708.
2003
-
Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes..
41:31S-36S.
2003
-
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial..
41:386-393.
2003
-
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients..
41:371-380.
2003
-
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy..
40:2156-2164.
2002
-
Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry..
40:1555-1566.
2002
-
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines)..
40:1531-1540.
2002
-
The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study..
40:1199-1204.
2002
-
Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study..
40:1085-1091.
2002
-
Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability..
40:1034-1040.
2002
-
Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference..
40:603-615.
2002
-
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy..
40:271-277.
2002
-
Correlation of left ventricular diastolic filling characteristics with right ventricular overload and pulmonary artery pressure in chronic thromboembolic pulmonary hypertension..
40:318-324.
2002
-
Reply.
40:206-206.
2002
-
Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial..
39:1956-1963.
2002
-
Prognostic significance of elevated troponin I after percutaneous coronary intervention..
39:1738-1744.
2002
-
A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium..
39:1220-1228.
2002
-
Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure..
39:1170-1174.
2002
-
Advanced heart failure patients unable to reach ACE inhibitor targets: A high risk population identified during hospitalization.
39:185A-185A.
2002
-
Aging and patient preferences regarding invasive cardiac care.
39:197A-197A.
2002
-
Deficits in knowledge related to the QT interval that could impact patient safety.
39:125A-125A.
2002
-
Diabetes is associated with a higher risk of death than is prior myocardial infarction in the setting of coronary disease: Results from the Duke cardiovascular database.
39:329A-329A.
2002
-
Diabetes-related knowledge is not associated with measures of risk factor control in patients with diabetes and acute coronary syndromes.
39:443A-443A.
2002
-
Differential impact of antithrombotic treatments combined with tenecteplase in the elderly with acute myocardial infarction: Results from ASSENT-3.
39:306A-306A.
2002
-
Does Troponin positivity add prognostic value to quantitative ST segment depression in predicting death and myocardial infarction in non-ST elevation acute coronary syndrome patients?.
39:311A-311A.
2002
-
Effect of cardiac rehabilitation on functional outcomes following coronary revascularization.
39:151A-151A.
2002
-
Effects of antidepressant medication on mortality in patients with congestive heart failure.
39:168A-168A.
2002
-
Elevated troponin following percutaneous coronary intervention predicts subsequent events: Results from the ESPRIT trial.
39:72A-72A.
2002
-
Mitral regurgitation is an independent risk factor for mortality in patients with heart failure and left ventricular systolic dysfunction.
39:194A-194A.
2002
-
Opportunities for enhancing the use of evidence-based medicines for acute coronary syndromes: Insights from the Symphony studies.
39:303A-303A.
2002
-
Paradoxical use of angiography with advancing age: Insights from an international trial population.
39:152A-152A.
2002
-
Patients with CHF and depression have greater risk of mortality and morbidity than patients without depression..
39:919-921.
2002
-
Point-of-care measurement of platelet function before angioplasty strongly predicts future target vessel revascularization.
39:72A-72A.
2002
-
Racial differences in endocarditis treatment and outcome.
39:425A-426A.
2002
-
The abciximab ST-recovery on AMI (ASTRONAMI) GUSTO V substudy: Enhanced early speed, stability, and quality of reperfusion with anti-platelet augmented thrombolytic therapy for ST-elevation AMI.
39:306A-306A.
2002
-
Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial..
39:377-386.
2002
-
A standardized definition of ischemic cardiomyopathy for use in clinical research..
39:210-218.
2002
-
Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial..
39:266-273.
2002
-
Serial echocardiographic evaluation of restenosis after successful percutaneous mitral commissurotomy..
39:328-334.
2002
-
The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes..
39:22-29.
2002
-
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)..
38:2114-2130.
2001
-
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial..
38:1608-1613.
2001
-
The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry..
38:1456-1462.
2001
-
The impact of statistical adjustment on economic profiles of interventional cardiologists..
38:1416-1423.
2001
-
Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications..
38:1156-1162.
2001
-
Reply.
38:1268-1268.
2001
-
Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An Angiographic Trials Pool data experience..
38:624-630.
2001
-
Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial..
38:653-658.
2001
-
Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy..
38:876-882.
2001
-
Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model..
38:546-554.
2001
-
Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors..
38:534-540.
2001
-
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up..
38:1-7.
2001
-
Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME)..
38:143-149.
2001
-
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network..
38:64-71.
2001
-
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents..
37:2170-2214.
2001
-
Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes?.
37:1883-1890.
2001
-
Erratum: Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb (Journal of American College of Cardiology (2001) 37 (1001-1007)) [1].
37:2012.
2001
-
American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents..
37:1478-1492.
2001
-
Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children..
37:1129-1134.
2001
-
Measuring the effectiveness of medical care delivery..
37:998-1000.
2001
-
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes..
37:1001-1007.
2001
-
Prediction of operative mortality after valve replacement surgery..
37:885-892.
2001
-
A prospective, multicenter, international randomized trial comparing four reperfusion strategies in acute myocardial infarction: Principal report of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
37:342S-342S.
2001
-
Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trial.
37:343A-343A.
2001
-
Assessing the relationship between obesity and long-term clinical and economic outcomes in coronary artery disease patients.
37:508A-509A.
2001
-
Atrioventricular nodal block in acute myocardial infarction treated with thrombolytic therapy is common and portends poor prognosis: Results from large trials of thrombolytic therapy.
37:341S-341S.
2001
-
Bailout platelet GP IIb/IIIa inhibition in coronary stent implantation: Observations from the ESPRIT trial.
37:84A-84A.
2001
-
C-reactive protein elevation is common in rheumatic mitral valve stenosis and inversely correlates with success of percutaneous balloon mitral valve commissurotomy.
37:488A-488A.
2001
-
Cardiac conduction abnormalites complicating infective endocarditis.
37:431A-431A.
2001
-
Cardiac enzyme elevations after coronary artery bypass grafting associated with increased risk of death: Results from PARAGON-B.
37:359A-359A.
2001
-
Diabetes doubles the risk of death among patients presenting with acute coronary syndromes: Insights from SYMPHONY, a large international trial.
37:372A-373A.
2001
-
Does stenting and glycoprotein IIb/IIIa receptor blockade improve the prognosis of diabetics undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial.
37:342S-342S.
2001
-
Echocardiographic predictors of mortality in endocarditis: An analysis of 450 patients from the Duke endocarditis service.
37:490A-490A.
2001
-
Effect of anti arrhythmic treatment for sustained ventricular tachycardia in the setting of acute myocardial infarction.
37:357A-357A.
2001
-
Effect of glycoprotein IIb/IIIa receptor inhibition on in-lab adverse events and subsequent CK-MB elevation during percutaneous coronary intervention in ESPRIT.
37:84A-84A.
2001
-
Effect of stent implantation and glycoprotein IIb/IIIa receptor blockade on TIMI flow and mortality after primary PTCA in acute myocardial infarction: Final results of the CADILLAC Trial.
37:342S-342S.
2001
-
Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia..
37:616-623.
2001
-
Elevation of CK-MB greater than 2 fold and troponin greater than 3 fold are the best thresholds for identifying MI associated with ECG evolution.
37:115A-116A.
2001
-
Fewer bleeding complications with comparable efficacy with the transradial approach in coronary artery stenting: An analysis of the ESPRIT trial.
37:33A-33A.
2001
-
High-dose eptifibatide (Integrilin (R)) in coronary stent implantation: 1 year results of the ESPRIT trial.
37:76A-76A.
2001
-
Higher coronary intervention following acute MI associated with lower rates of evidence-based medical therapy in regions of North America: Results from ASSENT II.
37:351A-351A.
2001
-
Morbidly obese patients undergoing cardiac catheterization: Less disease, less aggressive revascularization, and similar outcomes.
37:367A-368A.
2001
-
Racial and geographic disparities in timing of bidirectional Glenn (BDG) and Fontan stages of single-ventricle palliation.
37:466A-466A.
2001
-
Representation of the elderly in cardiovascular clinical trials.
37:497A-497A.
2001
-
Risk of major bleeding in patients treated with PTCA early following thrombolysis with TNK vs. t-PA.
37:349A-350A.
2001
-
Robust benefit of platelet GP IIb-IIIa inhibition with eptifibatide in patients undergoing stent PCI with hot or cold presentation.
37:76A-77A.
2001
-
The effect of changing trends in endocarditis on outcomes.
37:473A-473A.
2001
-
The extent of coronary artery disease and long-term survival in patients with symptomatic left ventricular systolic dysfunction.
37:177A-177A.
2001
-
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators..
37:492-498.
2001
-
Trained and supervised physician assistants can safely perform diagnostic cardiac catheterization and coronary angiography.
37:515A-515A.
2001
-
Treatment effect at different levels of creatinine clearance following eptifibatide in planned coronary stent implantation.
37:11A-11A.
2001
-
Variations in event rates between Canada and United States in the EPISTENT trial.
37:81A-81A.
2001
-
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion..
37:9-18.
2001
-
Challenges in comparing risk-adjusted bypass surgery mortality results: results from the Cooperative Cardiovascular Project..
36:2174-2184.
2000
-
Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology..
36:2204-2211.
2000
-
Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing..
36:1985-1991.
2000
-
A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT)..
36:1500-1506.
2000
-
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial..
36:1489-1496.
2000
-
Erratum: Abnormal cardiac function in the streptozocin-induced, non-insulin-dependent diabetic rat. Noninvasive assessment with Doppler echocardiography and contribution of the nitric oxide pathway (Journal of the American College of Cardiology (2000) 36 (2111-9)).
36:2111-2119.
2000
-
Provisional stenting strategies: systematic overview and implications for clinical decision-making..
36:1142-1151.
2000
-
Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators..
36:794-802.
2000
-
Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration..
36:723-730.
2000
-
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction..
36:959-969.
2000
-
Circadian rhythm and sudden death in heart failure: results from Prospective Randomized Amlodipine Survival Trial..
36:541-546.
2000
-
Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent..
36:381-386.
2000
-
A randomized comparison of sibrafiban, an oral glycoprotein (GP) IIb/IIIa receptor antagonist, with and without aspirin versus aspirin after acute coronary syndromes (ACS): Results of the second symphony trial.
36:319-320.
2000
-
American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease..
36:326-340.
2000
-
Echocardiographic findings in fulminant and acute myocarditis..
36:227-232.
2000
-
High-dose eptifibatide in elective coronary stenting: Results of the ESPRIT trial.
36:321-321.
2000
-
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes..
35:1502-1512.
2000
-
American College of Cardiology/European Society of Cardiology International Study of Angiographic Data Compression Phase I: The effect of lossy data compression on recognition of diagnostic features in digital coronary angiography..
35:1370-1379.
2000
-
Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST)..
35:1116-1121.
2000
-
The role of the American College of Cardiology in promoting and maintaining the delivery of quality cardiovascular care in the future..
35:99B-101B.
2000
-
Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina..
35:907-914.
2000
-
The role of the American College of Cardiology in promoting and maintaining the delivery of quality cardiovascular care in the future..
35:1100-1102.
2000
-
Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network..
35:731-738.
2000
-
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment..
35:666-672.
2000
-
A comparison of transesophageal and intracardiac induction of atrial fibrillation in children: Implications in Wolff-Parkinson-White syndrome.
35:516A-517A.
2000
-
Abciximab thrombocytopenia: Clinical correlates and outcomes.
35:91A-92A.
2000
-
Clinical features of patients with heart failure after an acute coronary syndrome: Findings from GUSTO-IIb.
35:212A-213A.
2000
-
Depression in heart failure: Clinical characteristics and impact on outcomes.
35:178A-178A.
2000
-
Elevated CK-MB following coronary intervention in patients with acute coronary syndromes is associated with a four-fold increase in mortality: Results from the GUSTO-IIb and PURSUIT trials.
35:40A-40A.
2000
-
Higher aPTTs associated with worse outcomes after thrombolytic therapy with reduced-dose heparin: Results from ASSENT-2.
35:372A-372A.
2000
-
Hirudin significantly reduces ischemic events following coronary intervention for acute coronary syndromes.
35:39A-40A.
2000
-
Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging..
35:477-484.
2000
-
Incremental effects of anti-platelet, anti-thrombin and fibrinolytic therapy on the speed and stability of ST-Segment recovery after acute MI.
35:372A-372A.
2000
-
Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs..
35:519-526.
2000
-
One year follow-up after intravascular radiation therapy following balloon angioplasty of narrowed femoral-popliteal arteries. Results of the PARIS feasibility clinical trial.
35:51A-51A.
2000
-
Prediction of operative mortality following valve replacement surgery.
35:529A-530A.
2000
-
Quality of life with end-stage coronary artery disease.
35:554A-554A.
2000
-
Quantitative electrocardiographic variables predict adverse outcomes in Non-ST elevation acute coronary syndromes: Results from GUSTO IIb.
35:410A-411A.
2000
-
Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries..
35:428-441.
2000
-
Serial echocardiographic and clinical follow up in medicare-aged patients undergoing Percutaneous Balloon Mitral Commissurotomy.
35:220A-220A.
2000
-
Temporal and regional differences in therapy for reinfarction following thrombolysis: Results from GUSTO I and ASSENT II.
35:386A-386A.
2000
-
The impact of abciximab on mortality after multivessel PCI: A striking effect in diabetics.
35:91A-91A.
2000
-
The influence of the BARI diabetic treatment alert on revascularization selection patterns: The NCN results.
35:544A-544A.
2000
-
The response to inhaled nitric oxide in adult patients with primary pulmonary hypertension and pulmonary hypertension from secondary causes.
35:286A-286A.
2000
-
Abnormal cardiac function in the streptozocin-induced, non-insulin-dependent diabetic rat. Noninvasive assessment with Doppler echocardiography contribution of the nitric oxide pathway (vol 36, pg 2111, 2000).
36:1454-1454.
2000
-
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction..
35:136-143.
2000
-
Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly..
35:119-126.
2000
-
Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway..
34:2111-2119.
1999
-
American College of Cardiology training statement on recommendations for the structure of an optimal adult interventional cardiology training program: a report of the American College of Cardiology task force on clinical expert consensus documents..
34:2141-2147.
1999
-
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial..
34:1711-1720.
1999
-
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries..
34:1729-1737.
1999
-
Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI)..
34:1750-1759.
1999
-
To stent or not to stent--that is the question..
34:1489.
1999
-
Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis..
34:1061-1066.
1999
-
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications..
34:12-19.
1999
-
Gender differences in molecular remodeling in pressure overload hypertrophy..
34:264-273.
1999
-
Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations..
33:1956-1963.
1999
-
The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes..
33:1833-1840.
1999
-
Acute and long-term cost implications of coronary stenting..
33:1610-1618.
1999
-
ACC expert consensus document on ethical coding and billing practices for cardiovascular medicine specialists. American College of Cardiology..
33:1076-1086.
1999
-
Perioperative morbidity and mortality after transmyocardial laser revascularization: incidence and risk factors for adverse events..
33:1021-1026.
1999
-
The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group..
33:661-669.
1999
-
Erratum: Value of exercise treadmill testing in women. Low dose dobutamine echocardiography predicts improvement in functional capacity after exercise training in patients with ischemic cardiomyopathy (Journal of the American College of Cardiology (1998) 32 (1657-1664)).
33:289.
1999
-
Echocardiography in emergency medicine: a policy statement by the American Society of Echocardiography and the American College of Cardiology. Task Force on Echocardiography in Emergency Medicine of the American Society of Echocardiography and the Echocardiography and Technology and Practice Executive Committees of the American College of Cardiology..
33:586-588.
1999
-
ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association..
33:273-282.
1999
-
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II..
33:88-96.
1999
-
Dynamic left ventricular outflow tract obstruction as a potential mechanism of myocardial rupture after acute myocardial infarction [4] (multiple letters).
34:2150-2151.
1999
-
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists observations from the thrombolysis and thrombin inhibition in myocardial infarction 9 study.
33:479-487.
1999
-
Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: Potential mechanisms for heightened prothrombotic potential.
34:1020-1027.
1999
-
Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial..
32:2003-2010.
1998
-
Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial..
32:2023-2030.
1998
-
Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion..
32:1756-1764.
1998
-
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Blockade..
32:1619-1623.
1998
-
Value of exercise treadmill testing in women..
32:1657-1664.
1998
-
Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload..
32:1118-1125.
1998
-
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions..
32:936-941.
1998
-
The effects of New York's bypass surgery provider profiling on access to care and patient outcomes in the elderly..
32:993-999.
1998
-
ACC expert consensus document. Present use of bedside right heart catheterization in patients with cardiac disease. American College of Cardiology..
32:840-864.
1998
-
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries..
32:634-640.
1998
-
The ACC professional life survey: career decisions of women and men in cardiology. A report of the Committee on Women in Cardiology. American College of Cardiology..
32:827-835.
1998
-
Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment Evaluation..
32:387-392.
1998
-
Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group..
32:311-319.
1998
-
Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries..
31:1466-1473.
1998
-
Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis..
31:1518-1524.
1998
-
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators..
31:1493-1498.
1998
-
Echocardiography in Staphylococcus aureus bacteremia - Reply.
31:1444-1445.
1998
-
Echocardiography in Staphylococcus aureus bacteremia..
31:1443-1445.
1998
-
ACC expert consensus document. Radiation safety in the practice of cardiology. American College of Cardiology..
31:892-913.
1998
-
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy..
31:783-789.
1998
-
Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures: Statement of the American College of Cardiology..
31:722-743.
1998
-
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries..
31:497-505.
1998
-
A Comparison of Static Serial vs Continuous ST-Segment Recovery to Predict Outcome After Lytics for MI.
31:228A-229A.
1998
-
Abciximab Associated Thrombocytopenia: Evidence for a Complex Interaction With Heparin.
31:55A-55A.
1998
-
Comparison of Stroke Rates in Patients With Acute Coronary Syndromes and Patients With Acute Myocardial Infarction.
31:406A-406A.
1998
-
Complementarity of Stenting and Abciximab for Percutaneous Coronary Intervention.
31:54A-54A.
1998
-
Disagreement Between Site Investigators and Clinical Event Committees is Common and Can Affect Trial Results.
31:184A-185A.
1998
-
Do PTCA Mortality Outcomes Need to Be Risk-adjusted? Results From the National Cardiovascular Network (NCN).
31:173A-173A.
1998
-
Does Stenting Benefit the Very Elderly? An Analysis of Device-specific Outcomes in 3,740 Octogenarians.
31:77A-77A.
1998
-
Effect of Plasma Homocyst(e)ine Levels on Adverse Cardiovascular Outcomes After PTCA or CABG in EAST.
31:89A-89A.
1998
-
Evaluation of Ventricular Outflow Tract Abnormalities Using Real-time Three-dimensional Echocardiography.
31:516A-517A.
1998
-
Gender Differences in Device Selection and Procedural Outcome: A National Cardiovascular Network (NCN) Report.
31:234A-234A.
1998
-
Heparin Dosing and Outcome in Acute Coronary Syndromes: The GUSTO-IIb Experience.
31:78A-78A.
1998
-
Hirudin Reduces Death and Myocardial (Re)infarction at 6-Months: Follow-up Results of the GUSTO IIb Trial.
31:79A-79A.
1998
-
Mortality Following Acute Myocardial Infarction According to Physician Experience, Technical Training, and Specialty.
31:363A-363A.
1998
-
Myonecrosis after revascularization procedures..
31:241-251.
1998
-
Passive Acoustic Imaging for Non-invasive Detection and Localization of Coronary Artery Disease: Detection Threshold in an In-Vitro Model.
31:219A-219A.
1998
-
Predicting Mortality Following PTCA: Results From NCN.
31:179A-179A.
1998
-
Prospective Study of Clinical Outcome in Endocarditis Patients.
31:464A-464A.
1998
-
Reduction in Heart Failure Events by Clinical Pharmacist Intervention: Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study.
31:69A-69A.
1998
-
ST-Segment Parameters and the GUSTO-I Mortality Model: Another Risk-Stratification Tool in Acute Myocardial Infarction.
31:346A-346A.
1998
-
Safety of Readministration of Abciximab; Interim Results of the ReoPro Readministration Registry (R3).
31:55A-55A.
1998
-
Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries..
31:105-110.
1998
-
Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.
31:352-358.
1998
-
Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease..
31:10-19.
1998
-
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries..
31:94-102.
1998
-
Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction.
31:1226-1233.
1998
-
Cardiac morphology and function in senescent rats: gender-related differences..
30:1872-1877.
1997
-
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries..
30:1606-1610.
1997
-
Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarction..
30:1478-1483.
1997
-
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy..
30:1002-1008.
1997
-
Impact of early discharge after coronary artery bypass graft surgery on rates of hospital readmission and death. The Ischemic Heart Disease (IHD) Patient Outcomes Research Team (PORT) Investigators..
30:908-913.
1997
-
Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients..
30:1072-1078.
1997
-
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries..
30:708-715.
1997
-
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries..
30:406-413.
1997
-
ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing)..
30:260-311.
1997
-
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries..
30:171-179.
1997
-
Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation..
30:35-41.
1997
-
Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock..
29:1454-1458.
1997
-
Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels..
29:1102-1106.
1997
-
Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction..
29:1109-1116.
1997
-
ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography..
29:862-879.
1997
-
Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators..
29:770-777.
1997
-
Abciximab (c7E3 fab, ReoPro) with reduced heparin dosing during coronary intervention: Final results of the EPILOG trial.
29:7396-7396.
1997
-
Benefits of abciximab accrue in the full spectrum of coronary interventional patients: Insights from the EPILOG trial.
29:9931-9931.
1997
-
Bleeding with coronary artery bypass surgery (CABG) in patients treated with a platelet glycoprotein IIb/IIIa inhibitor.
29:52128-52128.
1997
-
Combining IIb/IIIa inhibition and heparin for acute coronary syndromes: Evidence of a gradient for bleeding hazard from the PARAGON randomized factorially designed trial.
29:3338-3338.
1997
-
Comparison of three coronary bypass mortality prediction models: Results from the national cardiovascular network.
29:64170-64170.
1997
-
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries..
29:240-249.
1997
-
Cost-effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias.
29:36103-36103.
1997
-
Direct angioplasty may be less advantageous in patients presenting early after symptom onset: Results from GUSTO IIb.
29:7811-7811.
1997
-
Early catheterization is standard strategy in unstable angina/NQWMI: Results from GUSTO IIb.
29:5614-5614.
1997
-
Economic assessment of platelet glycoprotein IIb/IIa receptor blockade during coronary intervention in the EPILOG trial.
29:97484-97484.
1997
-
Endpoint adjudication by a clinical events committee can impact the statistical outcome of a clinical trial: Results from GUSTO-IIb.
29:3339-3339.
1997
-
Evolving trends in angioplasty device selection: A national cardiovascular network (NCN) database report.
29:8034-8034.
1997
-
Is continuous ST monitoring a better predictor outcome than enrolling electrocardiogram in acute myocardial infarction?.
29:44106-44106.
1997
-
Is the ECG adequate to identify patients with left circumflex occlusion in acute coronary syndromes?.
29:78128-78128.
1997
-
Is there a differential benefit of ReoPro during PTCA for patients with certain lesion types?.
29:8012-8012.
1997
-
Long-term echocardiographic assessment of restenosis after balloon mitral commissurotomy.
29:7665-7665.
1997
-
Medical interventions in unstable angina: Does international clinical practice match evidence-based guidelines?.
29:23138-23138.
1997
-
Mortality, morbidity, resource use and quality of life following Q- vs non-Q-wave infarction and thrombolytic therapy: A GUSTO-I substudy.
29:78106-78106.
1997
-
Noninvasive identification of the infarct related artery from zone activity in the true peak surface 12 lead ECG.
29:44104-44104.
1997
-
Outcome of acute myocardial infarction by physician specialty.
29:7993-7993.
1997
-
Post-MI testing in the elderly: Results in 190,135 patients.
29:7775-7775.
1997
-
Reducing the risk of percutaneous intervention after coronary bypass surgery: Beneficial effects of abciximab treatment.
29:7395-7395.
1997
-
Regional variation in post-MI testing: Results in 190,237 pts.
29:7995-7995.
1997
-
Relationship of outcomes to treatment with lamifiban in patients undergoing PTCA: Analysis of PARAGON A.
29:3334-3334.
1997
-
ST-segment recovery parameters predictive of outcome in AMI: Variability with infarct artery location and implications for therapeutic targets.
29:3455-3455.
1997
-
Temporal distribution of important ECG information in patients with MI: When should you take the next ECG after lytics?.
29:9466-9466.
1997
-
The effect of balloon mitral commissurotomy on atrial rhythm.
29:7663-7663.
1997
-
The paradigm for anti-platelet effect on continuous 12-lead ST-segment recovery in acute MI.
29:7383-7383.
1997
-
Upright posture with a flexible femoral sheath: Safety and cost results from 900 patients in the ''heads up'' trial.
29:9938-9938.
1997
-
Use of abciximab (ReoPro(R)) is not associated with an increase in the risk of stroke: Overview of three randomized trials.
29:97489-97489.
1997
-
Use of diagnostic tools in a chest pain evaluation unit: Value of troponin T testing.
29:7562-7562.
1997
-
Ventricular fibrillation originates in low potential gradient regions following sub-threshold defibrillation shocks regardless of shock electrode configuration.
29:46130-46130.
1997
-
Weight adjusted antithrombotic regimens eliminate the nitroglycerin-antithrombotic interaction.
29:3453-3453.
1997
-
What predicts contrast nephropathy after coronary intervention? Insights from the IMPACT II trial.
29:8210-8210.
1997
-
Outcome and profile of women and men presenting with acute coronary syndromes: A report from TIMI IIIB.
30:141-148.
1997
-
Thrombolysis, the risk of rupture and other risks [1].
29:221-222.
1997
-
Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project..
28:1478-1487.
1996
-
Non-Q wave infarction after thrombolytic therapy..
28:1638-1639.
1996
-
Diet and secondary prevention of coronary disease: is it time to stop chewing the fat?.
28:1109-1110.
1996
-
Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions..
28:1111-1118.
1996
-
Coronary artery stents. American College of Cardiology..
28:782-794.
1996
-
Long-term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction..
28:773-781.
1996
-
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients..
28:305-312.
1996
-
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators..
27:1646-1655.
1996
-
Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)..
27:1327-1332.
1996
-
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management..
27:1007-1019.
1996
-
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial..
27:625-632.
1996
-
Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure..
27:720-727.
1996
-
A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction.
27:1321-1326.
1996
-
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR)..
27:1-7.
1996
-
Transesophageal echocardiography versus oral anticoagulation before electrical cardioversion of atrial fibrillation: what about atrial clot size?.
27:251-252.
1996
-
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial..
26:1651-1656.
1995
-
Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival..
26:1522-1528.
1995
-
Better functional status in American than Canadian patients with heart disease: an effect of medical care?.
26:1115-1120.
1995
-
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries..
26:1222-1229.
1995
-
The 49th parallel: how much latitude?.
26:1123-1124.
1995
-
Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)..
26:922-930.
1995
-
Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry..
26:688-695.
1995
-
Percutaneous revascularization of chronic coronary occlusions: an overview..
26:1-11.
1995
-
Percutaneous transluminal coronary angioplasty as a first revascularization procedure in single-, double- and triple-vessel coronary artery disease..
26:142-151.
1995
-
Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT)..
25:1693-1699.
1995
-
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries..
25:1552-1557.
1995
-
Comparison of defibrillation probability of success curves for an endocardial lead configuration with and without an inactive epicardial patch..
25:1373-1379.
1995
-
Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study..
25:1354-1361.
1995
-
Heterogeneity of vasomotor response to acetylcholine along the human coronary artery..
25:1046-1055.
1995
-
Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia..
25:984-988.
1995
-
Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia..
25:610-618.
1995
-
908-108 Outcome of Patients with Acute Myocardial Infarction and Bundle Branch Block in the Thrombolytic Era: Observations from GUSTO.
25:59A-60A.
1995
-
Cardiac rupture associated with thrombolytic therapy: Impact of time to treatment in the late assessment of thrombolytic efficacy (LATE) study.
25:1063-1068.
1995
-
Effect of dobutamine stress echocardiography on mitral regurgitation..
25:122-127.
1995
-
Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 4: training in echocardiography..
25:16-19.
1995
-
Reply.
25:553.
1995
-
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease..
24:874-880.
1994
-
Predicting the risk of abrupt vessel closure after angioplasty in an individual patient..
24:1004-1011.
1994
-
Cardiac angiography without cine film: erecting a "Tower of Babel" in the cardiac catheterization laboratory. American College of Cardiology Cardiac Catheterization Committee..
24:834-837.
1994
-
Clinical utility of transthoracic two-dimensional and Doppler echocardiography..
24:125-131.
1994
-
Percutaneous transluminal coronary angioplasty in women compared with men..
24:81-90.
1994
-
Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation..
23:1535-1540.
1994
-
Acute complications of excimer laser coronary angioplasty: a detailed analysis of multicenter results. Coinvestigators of the U.S. and European Percutaneous Excimer Laser Coronary Angioplasty (PELCA) Registries..
23:1305-1313.
1994
-
Catheter ablation of sinoatrial node reentrant tachycardia..
23:926-934.
1994
-
Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group..
23:891-898.
1994
-
Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children..
23:766-771.
1994
-
BLEEDING ASSOCIATED WITH USE OF A PLATELET GLYCOPROTEIN IIBIIA INHIBITOR DURING ROUTINE CORONARY ANGIOPLASTY - IS TOO MUCH HEPARIN THE CULPRIT.
A106-A106.
1994
-
CARDIAC BLOOD-VOLUME AND GEOMETRY INFLUENCE UPPER LIMIT OF VULNERABILITY AND ITS RELATIONSHIP TO DEFIBRILLATION THRESHOLD.
A325-A325.
1994
-
CHRONIC TOTAL CORONARY-OCCLUSION OF AN ISOLATED VESSEL IN 891 PATIENTS OVER 24 YEARS - IS MEDICAL-MANAGEMENT AND ADEQUATE APPROACH.
A390-A390.
1994
-
DIFFERENTIAL EFFECT OF ACETYLCHOLINE ON ATRIAL AND VENTRICULAR RESISTANCE VESSELS ISOLATED FROM HUMAN HEARTS.
A427-A427.
1994
-
DIFFERENTIATION OF BENIGN MIRROR-IMAGE FROM HIGH-RISK RECIPROCAL ST DEPRESSION USING CONTINUOUS 12-LEAD ST-SEGMENT RECOVERY ANALYSIS.
A195-A195.
1994
-
DO WOMEN WITH CORONARY-DISEASE TRULY GET TREATED DIFFERENTLY THAN MEN.
A298-A298.
1994
-
DOES THE USE OF HIGH INFLATION PRESSURES ADVERSELY AFFECT THE ACUTE AND LONG-TERM OUTCOME OF CORONARY ANGIOPLASTY.
A352-A352.
1994
-
GENDER DIFFERENCES IN SPEED AND STABILITY OF CORONARY REPERFUSION FOLLOWING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION.
A316-A316.
1994
-
IMMEDIATE, REVERSIBLE PLATELET-AGGREGATION INHIBITION IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY.
A106-A106.
1994
-
PATIENT SATISFACTION WITH HEALTH-CARE IS INSENSITIVE TO VARIATIONS IN CARE RECEIVED AND QUALITY-OF-LIFE - UNITED-STATES CANADA GUSTO SUBSTUDY RESULTS.
A166-A166.
1994
-
QUANTITATIVE ANGIOGRAPHIC ANALYSIS OF VEIN GRAFT LESIONS TREATED WITH EXCIMER-LASER ANGIOPLASTY - IMMEDIATE AND FOLLOW-UP RESULTS.
A449-A449.
1994
-
RAPID PACING MOVES THE UPPER LIMIT OF VULNERABILITY HIGHER ON THE DEFIBRILLATION PROBABILITY OF SUCCESS CURVE.
A293-A293.
1994
-
THE NATIONAL MEDICARE EXPERIENCE - CHANGING PATTERNS OF MYOCARDIAL REVASCULARIZATION UTILIZATION AND OUTCOME.
A438-A438.
1994
-
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
23:993-1003.
1994
-
A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: the Duke University Clinical Cardiology Study (DUCCS) 1..
23:11-18.
1994
-
Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group..
22:1780-1787.
1993
-
Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial..
22:1494-1500.
1993
-
Dual natriuretic peptide system in experimental heart failure..
22:891-898.
1993
-
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study..
22:381-389.
1993
-
Atrial ejection force: a noninvasive assessment of atrial systolic function..
22:221-225.
1993
-
Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty..
22:127-134.
1993
-
Coronary artery perforation during excimer laser coronary angioplasty. The percutaneous Excimer Laser Coronary Angioplasty Registry..
21:1158-1165.
1993
-
Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group..
21:920-925.
1993
-
Can restenosis after coronary angioplasty be predicted from clinical variables?.
21:6-14.
1993
-
Erratum: Ergonovine maleate testing during cardiac catheterization: A 10-year perspective in 3,447 patients without significant coronary artery disease or Printzmetal's variant angina (J Am Coll Cardiol 1992; 20: 107-111).
21:848.
1993
-
New method for evaluation of arterial properties by three-element windkessel.
21:61A-61A.
1993
-
Right ventricular systolic performance in a porcine model.
21:421A-421A.
1993
-
Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era..
20:1482-1489.
1992
-
Intracoronary ultrasound predictors of adverse outcomes after coronary artery interventions..
20:1385-1390.
1992
-
Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group..
20:1313-1317.
1992
-
Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans..
20:594-598.
1992
-
Prevalence and mortality rate of congestive heart failure in the United States..
20:301-306.
1992
-
Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina..
20:107-111.
1992
-
Remodeling and reparation of the cardiovascular system..
20:3-16.
1992
-
Comparison of preload recruitable stroke work, end-systolic pressure-volume and dP/dtmax-end-diastolic volume relations as indexes of left ventricular contractile performance in patients undergoing routine cardiac catheterization..
19:1522-1530.
1992
-
Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion.
19:1123-1128.
1992
-
Two-dimensional and Doppler echocardiographic determinants of the natural history of mitral valve narrowing in patients with rheumatic mitral stenosis: implications for follow-up..
19:968-973.
1992
-
Left ventricular function is not impaired in weight-lifters who use anabolic steroids..
19:278-282.
1992
-
Mechanical correlates of the third heart sound..
19:450-457.
1992
-
Creatinine kinase kinetics studied by phosphorus-31 nuclear magnetic resonance in a canine model of chronic hypertension-induced cardiac hypertrophy..
19:223-228.
1992
-
Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction. TAMI-5 Study Group..
18:1594-1601.
1991
-
ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories. American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization..
18:1149-1182.
1991
-
Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group..
17:1451-1457.
1991
-
RESTENOSIS AFTER CORONARY ANGIOPLASTY - AN OVERVIEW.
17:B2-B13.
1991
-
Restenosis after coronary angioplasty: an overview..
17:2B-13B.
1991
-
Follow-up recatheterization after balloon aortic valvuloplasty. Mansfield Scientific Aortic Valvuloplasty Registry Investigators..
17:1188-1195.
1991
-
Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension..
17:530-536.
1991
-
Phasik characteristics of transaortic pressure gradients in valvular aortic stenosis.
17:A254-A254.
1991
-
Noninvasive assessment of intrinsic ventricular load dynamics in dilated cardiomyopathy..
17:112-121.
1991
-
Phasic characteristics of transaortic pressure gradients in valvular aortic stenosis.
17:254A-254A.
1991
-
Serial left ventricular performance evaluated by cardiac catheterization before, immediately after and at 6 months after balloon aortic valvuloplasty..
16:1351-1358.
1990
-
Changes in left ventricular diastolic performance after aortic balloon valvuloplasty: acute and late effects..
16:795-803.
1990
-
Randomized comparison of the cost and effectiveness of iopamidol and diatrizoate as contrast agents for cardiac angiography..
16:871-877.
1990
-
Intravascular ultrasonography versus digital subtraction angiography: a human in vivo comparison of vessel size and morphology..
16:633-636.
1990
-
Response of atrial natriuretic factor to postural change in patients with heart failure versus subjects with normal hemodynamics..
16:599-606.
1990
-
Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis..
16:533-540.
1990
-
Augmentation of mortality risk discriminating power of left ventricular ejection fraction by measures of nonuniformity in systolic emptying on radionuclide ventriculography..
16:387-395.
1990
-
Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis..
16:359-367.
1990
-
Early ambulation after 5 French diagnostic cardiac catheterization: results of a multicenter trial..
15:1475-1483.
1990
-
Relation of quantitative coronary lesion measurements to the development of exercise-induced ischemia assessed by exercise echocardiography..
15:1043-1051.
1990
-
Balloon angioplasty of coarctation of the aorta evaluated with intravascular ultrasound imaging..
15:906-909.
1990
-
Clinical assessment of ventricular ejection dynamics with and without outflow obstruction..
15:859-882.
1990
-
Effect of the right ventricular isolation procedure on ventricular vulnerability to fibrillation..
15:730-736.
1990
-
Feasibility and cost-saving potential of outpatient cardiac catheterization..
15:378-384.
1990
-
The utility of transesophageal echocardiography and Doppler color flow imaging in patients undergoing cardiac valve surgery..
15:363-372.
1990
-
Clinical judgment and therapeutic decision making..
15:1-14.
1990
-
Color flow doppler versus 2-dimensional echocardiography in the identification of post-infarction ventricular septal defect.
15:1200.
1990
-
Different effects of prolonged exercise on the right and left ventricles..
15:64-69.
1990
-
Myocardial salvage after failed coronary angioplasty..
15:78-82.
1990
-
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group..
14:877-884.
1989
-
Painless exercise ST deviation on the treadmill: long-term prognosis..
14:885-892.
1989
-
Task Force III: Assessment of psychological status in patients with ischemic heart disease..
14:1034-1042.
1989
-
Data for cardiovascular modeling..
14:60A-64A.
1989
-
ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome..
13:1495-1502.
1989
-
Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction..
13:1469-1476.
1989
-
Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival--a report from the Coronary Artery Surgery Study..
13:531-537.
1989
-
Alterations in diastolic function in response to progressive left ventricular hypertrophy..
13:461-467.
1989
-
Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy..
13:311-315.
1989
-
Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure..
13:173-179.
1989
-
Left ventricular isovolumic contraction period vanishes during intense exercise.
13:102A-102A.
1989
-
A comparison of paramedic versus basic emergency medical care of patients at high and low risk during acute myocardial infarction..
12:1555-1561.
1988
-
Administration of thrombolytic therapy in the community hospital: established principles and unresolved issues..
12:32A-43A.
1988
-
Insights derived from the thrombolysis and angioplasty in myocardial infarction (TAMI) trials..
12:24A-31A.
1988
-
Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile..
12:1573-1581.
1988
-
On mechanisms of improved ejection fraction by early reperfusion in acute myocardial infarction: myocardial salvage or infarct stiffening?.
12:1037-1038.
1988
-
Responsiveness of atrial natriuretic factor to reduction in right atrial pressure in patients with chronic congestive heart failure..
11:1191-1198.
1988
-
Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction..
11:1141-1149.
1988
-
Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty..
11:970-976.
1988
-
Comparison of time domain and frequency domain variables from the signal-averaged electrocardiogram: a multivariable analysis..
11:1041-1051.
1988
-
Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease..
11:962-969.
1988
-
Transluminal intracoronary reperfusion catheter: a device to maintain coronary perfusion between failed coronary angioplasty and emergency coronary bypass surgery..
11:977-982.
1988
-
Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty..
11:698-705.
1988
-
Echocardiographic visualization of coronary artery anatomy in the adult..
11:565-571.
1988
-
Postural exercise abnormalities in symptomatic patients with mitral valve prolapse..
11:499-507.
1988
-
Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery..
11:237-245.
1988
-
Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease..
11:20-26.
1988
-
Prognostic value of the simplified Selvester QRS score in patients with coronary artery disease..
11:35-41.
1988
-
A standardized examination in the interpretation of electrocardiograms..
10:882-886.
1987
-
Cardiovascular disease in the elderly. Behavioral, cognitive and emotional considerations..
10:38A-41A.
1987
-
Medical therapy in the elderly..
10:29A-34A.
1987
-
In vitro color flow, pulsed and continuous wave Doppler ultrasound masking of flow by prosthetic valves..
9:1306-1310.
1987
-
Comparison of echocardiographic methods for assessment of left ventricular shortening and wall stress..
9:945-951.
1987
-
Comparison of survival of amiodarone-treated patients with coronary artery disease and malignant ventricular arrhythmias with that of a control group with coronary artery disease..
9:877-881.
1987
-
Histologic and biochemical correlates of left ventricular chamber dynamics in man..
9:734-742.
1987
-
Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure..
9:420-425.
1987
-
THE INCIDENCE OF PERSISTENT HYPERLIPIDEMIAS AFTER CORONARY-ARTERY BYPASS-GRAFTING.
9:A86-A86.
1987
-
Right ventricular hemodynamic abnormalities in hypertrophic cardiomyopathy.
9:A231-A231.
1987
-
Real-time orthogonal mode scanning of the heart. I. System design..
7:1279-1285.
1986
-
Utility of echocardiography in the management of patients with penetrating missile wounds of the heart..
7:1151-1156.
1986
-
Value and limitation of biplane rest and exercise radionuclide angiography for assessing individual bypass grafts: a prospective study..
7:1004-1014.
1986
-
INFLUENCE OF OPERATIVE THERAPY ON LONG-TERM PROGNOSIS IN PATIENTS WITH 3-VESSEL CORONARY-ARTERY DISEASE.
7:A217-A217.
1986
-
Subvalvular left ventricular pseudoaneurysm after mitral valve replacement: two-dimensional echocardiographic findings..
6:1164-1166.
1985
-
Ultrasound diagnosis of pseudoaneurysm and contiguous ventricular septal defect complicating inferior myocardial infarction..
6:1160-1163.
1985
-
Prognostic value of a coronary artery jeopardy score..
5:1055-1063.
1985
-
Rapid ventricular filling in left ventricular hypertrophy: I. Physiologic hypertrophy..
5:862-868.
1985
-
NORMAL CORONARIES - NORMAL PROGNOSIS.
5:519-519.
1985
-
Effects of atrial fibrillation on myocardial blood flow in the ischemic heart of the dog..
4:729-734.
1984
-
Basic emergency medical care of patients with acute myocardial infarction: initial prehospital characteristics and in-hospital complications..
4:487-492.
1984
-
Accuracy and interobserver variability of coronary cineangiography: a comparison with postmortem evaluation..
3:1145-1154.
1984
-
GEOMETRY DEPENDENCE OF RADIONUCLIDE EJECTION FRACTION - EFFECTS OF DIFFERENTIAL ATTENUATION DURING REGIONAL HYPOKINESIS.
3:540-540.
1984
-
The safety of contrast echocardiography: report of the Committee on Contrast Echocardiography for the American Society of Echocardiography..
3:6-13.
1984
-
Prognostic value of ventricular arrhythmias associated with treadmill exercise testing in patients studied with cardiac catheterization for suspected ischemic heart disease..
2:1060-1067.
1983
-
A noninvasive radiographic technique for evaluation of exercise-induced changes in cardiac function..
2:318-326.
1983
-
Diagnostic and prognostic significance of exercise-induced premature ventricular complexes in men and women: a four year follow-up..
1:1201-1206.
1983
-
Diastolic abnormalities of hypertrophic cardiomyopathy reproduced by asynchrony of the left-ventricle in conscious dogs.
1:641-641.
1983
-
PHOTOAFFINITY-LABELING OF THE HUMAN MYOCARDIAL BETA-ADRENERGIC-RECEPTOR.
1:1183-1183.
1983
-
Erratum: Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV Dysfunction (Journal of the American College of Cardiology (2014) 12:64 (553-6)).
64:1539.
2014
-
Reply.
52:584-586.
2008
-
THE NEW POSITIVE INOTROPIC AGENTS FUNCTIONALLY BLOCK NI, THE INHIBITORY REGULATOR OF ADENYLATE-CYCLASE (Abstract).
9:A2-A2.
1987
-
IMMUNE CHECKPOINT INHIBITOR-INDUCED AORTITIS TREATED WITH TOCILIZUMAB
2022
-
ASSOCIATION BETWEEN BLOOD TYPE AND OUTCOMES OF BRIDGE-TO-TRANSPLANT LEFT VENTRICULAR ASSIST DEVICE THERAPY: ANALYSIS OF THE UNITED NETWORK FOR ORGAN SHARING (UNOS) REGISTRY
2022
-
CHARACTERISTICS AND OUTCOMES OF ADULTS WITH CONGENITAL HEART DISEASE IN THE CARDIAC INTENSIVE CARE UNIT: INSIGHTS FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK REGISTRY
2022
-
CLASSIFICATION AND IMPLICATIONS OF HEART FAILURE EVENTS FROM THE VICTORIA TRIAL
2022
-
COMPARING VOLUME VERSUS QUALITY THRESHOLDS ON OUTCOMES AND ACCESS TO TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IN THE UNITED STATES: INSIGHTS FROM THE TVT REGISTRY
2022
-
CORRELATION BETWEEN HOSPITAL PROCEDURAL VOLUMES AND OUTCOMES FOR TAVR AND MTEER IN THE UNITED STATES: A STS/ACC TVT REGISTRY ANALYSIS
2022
-
DECONGESTION, QUALITY OF LIFE, AND CLINICAL OUTCOMES AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE WITH REDUCED VERSUS PRESERVED EJECTION FRACTION
2022
-
EFFECTIVENESS AND SAFETY OF ASPIRIN IN SECONDARY PREVENTION OF CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A SUBGROUP ANALYSIS OF ADAPTABLE
2022
-
EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS AMONG MEDICARE PATIENTS WITH ATRIAL FIBRILLATION AND CANCER
2022
-
FUNCTIONAL AND SYMPTOMATIC CLINICAL ENDPOINTS IN HEART FAILURE RESEARCH: INSIGHTS FROM THE HEART FAILURE COLLABORATORY (HFC) - ACADEMIC RESEARCH CONSORTIUM (ARC) SCIENTIFIC EXPERT PANEL
2022
-
HIGH FREQUENCY OF CLINICALLY MEANINGFUL CHANGE IN CARDIOMYOPATHY-ASSOCIATED VARIANT PATHOGENICITY ASSIGNMENT IS DRIVEN BY DISPARITIES IN INCLUSION OF DIVERSE ANCESTRIES AMONG GENETIC STUDIES
2022
-
INCIDENCE, PREDICTORS, AND CLINICAL IMPACT OF RECOVERY IN LEFT VENTRICULAR SYSTOLIC FUNCTION AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION IN THE STS/ACC TVT REGISTRY
2022
-
NOAC USE IS SAFE AND EFFECTIVE FOR PATIENTS WITH ATRIAL FIBRILLATION AND REDUCED RENAL FUNCTION: RESULTS FROM COMBINE-AF
2022
-
SEX DIFFERENCES IN EFFECTIVENESS AND SAFETY OF ASPIRIN IN SECONDARY PREVENTION OF CARDIOVASCULAR OUTCOMES IN PATIENTS: A SUBGROUP ANALYSIS FROM THE ADAPTABLE STUDY
2022
-
SPLANCHNIC NERVE MODULATION EFFECTS ON SURROGATES MEASURES OF VENOUS COMPLIANCE
2022
-
TIME TO RELAPSE AFTER WEANING IMMUNE SUPPRESSIVE THERAPY IN CARDIAC SARCOIDOSIS: A SINGLE-CENTER EXPERIENCE
2022
-
TWO YEAR EXPERIENCE WITH HIGH-SENSITIVITY TROPONIN TESTING:INTERPRETATIVE VALUES FOR IMPROVING PATIENT DISPOSITION
2022
-
SECONDHAND SMOKE IS ASSOCIATED WITH PREVALENT HEART FAILURE: THE THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY
2021
-
STRESS-RELATED CHEST PAIN AND ASYMPTOMATIC MYOCARDIAL ISCHEMIA IN EXERCISE STRESS ECHOCARDIOGRAM IN DIABETICS AND NON-DIABETICS
2021
-
AN ANTITHROMBOTIC RESPONSE SIGNATURE SCORE IS A GENE EXPRESSION BIOMARKER OF BLEEDING RISK
2021
-
ASSOCIATION BETWEEN ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION, CARDIOVASCULAR BIOMARKERS AND CARDIAC REMODELING IN HEART FAILURE WITH REDUCED EJECTION FRACTION
2021
-
BRG1 IS A BIOMARKER OF HYPERTROPHIC CARDIOMYOPATHY IN HUMAN HEART SPECIMENS
2021
-
CARDIOVASCULAR DISEASE RISK FACTORS IN CHILDREN AND ADULTS WITH CONGENITAL HEART DISEASE ARE ASSOCIATED WITH HEART FAILURE: A POPULATION-BASED MULTI-SITE CROSS SECTIONAL ANALYSIS
2021
-
CONTEMPORARY PRACTICE IN SURGICAL MANAGEMENT OF CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES:AN ANALYSIS THE SOCIETYOF THORACIC SURGEONS CONGENITAL HEART SURGERY DATABASE(STS-CHD)
2021
-
Clinical Outcomes Among Patients With Severe Tricuspid Valve Regurgitation
2021
-
DAYS ALIVE OUT OF HOSPITAL WITH INITIAL INVASIVE VS CONSERVATIVE MANAGEMENT IN THE ISCHEMIA TRIAL
2021
-
EMERGENCY DEPARTMENT VISITS VERSUS HOSPITAL READMISSION AMONG PATIENTS WITH HEART FAILURE: FINDINGS FROM ASCEND-HF
2021
-
Five-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement: Excellent Valve-Specific Outcomes but Poor Overall Survival
2021
-
MODE OF DEATH FOR MEN AND WOMEN WITH ACUTE HEART FAILURE ACROSS THE SPECTRUM OF EJECTION FRACTION: FROM THE ASCEND-HF TRIAL
2021
-
NATIONAL TRENDS OF PERMANENT PACEMAKER IMPLANTATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: AN ANALYSIS FROM THE STS/ACC TVT REGISTRY
2021
-
ONE-YEAR COST-EFFECTIVENESS OF CYP2C19-GUIDED DE-ESCALATION AND ESCALATION OF P2Y12 INHIBITORS IN VETERANS WITH ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
2021
-
POSTPARTUM BLOOD PRESSURE SCREENING IN WOMEN WITH HYPERTENSIVE DISORDERS OF PREGNANCY
2021
-
Procedural and 30-Day Outcomes of Patients Undergoing TAVI-in-TAVI: Insights From the TVT Registry
2021
-
TEMPORAL TRENDS IN NON-CARDIOVASCULAR COMORBIDITIES AMONG PATIENTS HOSPITALIZED WITH ACUTE VS CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE ARIC STUDY
2021
-
THE ASSOCIATION OF GUIDELINE-BASED SURVEILLANCE AND LONG-TERM MORTALITY AMONG PATIENTS WITH MODERATE AND SEVERE MITRAL REGURGITATION
2021
-
Temporal Trends and Hospital Variation in Pacemaker Implantation Following TAVR-Insights From the STS/ACC TVT Registry
2021
-
USE OF NEGATIVE CONTROL OUTCOMES TO ASSESS THE COMPARABILITY OF TREATMENTS FOR HYPERCHOLESTEROLEMIA
2021
-
A NOVEL INFLAMMATORY MARKER OF GLYCOSYLATED PROTEINS IS ASSOCIATED WITH CAD AND INCIDENT EVENTS AND DEMONSTRATES AGE EFFECTS IN THE PROMISE TRIAL
2020
-
APIXABAN VERSUS WARFARIN AND ASPIRIN VERSUS PLACEBO ACCORDING TO RENAL FUNCTION AFTER ACUTE CORONARY SYNDROME OR PCI IN ATRIAL FIBRILLATION: INSIGHTS FROM THE AUGUSTUS TRIAL
2020
-
ASSOCIATION OF BODY MASS INDEX AND OUTCOMES AFTER TRANSCATHETER MITRAL VALVE REPAIR
2020
-
CARDIOVASCULAR HOSPITALIZATION AND REPEAT ABLATION RATES FOLLOWING CATHETER ABLATION AMONG ATRIAL FIBRILLATION PATIENTS TREATED WITH DRONEDARONE VS. SOTALOL
2020
-
CLINICAL AND ECHOCARDIOGRAPHIC PREDICTORS OF AORTIC STENOSIS DISEASE PROGRESSION AND CLINICAL OUTCOMES IN PATIENTS WITH MODERATE AORTIC STENOSIS
2020
-
CLINICAL CHARACTERISTICS OF "FAILING" ADULT FONTAN PATIENTS ACROSS 14 CENTERS: A REPORT FROM THE FOSTER STUDY
2020
-
COMPARISON OF YEARLY TRENDS IN LOCATION OF DEATH DUE TO HEART FAILURE VERSUS CANCER
2020
-
CONSCIOUS SEDATION VERSUS GENERAL ANESTHESIA FOR TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS OF AN INSTRUMENTAL VARIABLE ANALYSIS
2020
-
DIFFERENCES IN THERAPY AND DECONGESTION BETWEEN MEN AND WOMEN HOSPITALIZED FOR ACUTE HEART FAILURE: FINDINGS FROM ASCEND-HF
2020
-
DISPARITIES IN GROWTH OF TAVR IN THE UNITED STATES
2020
-
EVALUATING THE 2018 AHA/ACC LIPID GUIDELINE PERFORMANCE TO IDENTIFY PATIENTS AT HIGH RISK FOR PREMATURE CARDIOVASCULAR DISEASE
2020
-
HEMODYNAMIC EFFECTS OF NITROXYL DONOR BMS-986231 COMPARED TO NITROGLYCERIN OR PLACEBO IN PATIENTS WITH CHRONIC HEART FAILURE-A RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL
2020
-
IMPACT OF UNRECOGNIZED MYOCARDIAL SCAR DETECTED BY CARDIAC MAGNETIC RESONANCE IMAGING IN PATIENTS PRESENTING WITH SYMPTOMS OF CORONARY ARTERY DISEASE
2020
-
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) UTILIZATION AMONG OLDER PATIENTS WITH LOW EJECTION FRACTION FOLLOWING CORONARY REVASCULARIZATION FOR MYOCARDIAL INFARCTION
2020
-
LAWN MOWER VS. LEFT VENTRICULAR ASSIST DEVICE: A CASE OF TRAUMATIC CORONARY INJURY
2020
-
LIMITED TESTING FOR CORONARY ARTERY DISEASE IN PATIENTS WITH NEW-ONSET HEART FAILURE: FINDINGS FROM GET WITH THE GUIDELINES - HEART FAILURE
2020
-
MITRAL ANNULAR DISJUNCTION: WHEN YOU HAVE MAD, GET GAD(OLINIUM)
2020
-
MOLECULAR MARKERS OF SURVIVAL TO ADVANCED AGE WITH CARDIOVASCULAR DISEASE: RESULTS FROM THE MURDOCK STUDY
2020
-
MORBIDITY AND MORTALITY IN ADULT FONTAN PATIENTS AFTER HEART OR COMBINED HEART LIVER TRANSPLANT: A REPORT FROM THE FOSTER STUDY
2020
-
MORBIDITY AND MORTALITY IN ADULT FONTAN PATIENTS REFERRED FOR TRANSPLANT: A REPORT FROM THE FOSTER STUDY
2020
-
NO EASY OPTIONS: CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES AND LEFT VENTRICLE TO PULMONARY ARTERY CONDUIT STENOSIS
2020
-
PERIPHERAL VERSUS CENTRAL ACCESS FOR ALTERNATIVE ACCESS TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR): RESULTS FROM THE TVT REGISTRY
2020
-
PREDICTORS OF FFR UNDERUTILIZATION
2020
-
PREVALENCE OF POST-TRANSPLANT MALIGNANCIES IN HEART TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
2020
-
PREVALENCE, PREDICTORS AND OUTCOMES OF GASTROINTESTINAL(GI) BLEEDING FOLLOWING LEFT VENTRICLE ASSIST DEVICE (LVAD) IMPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
2020
-
RISK AND COSTS AFTER PERIPHERAL REVASCULARIZATION IN PATIENTS WITH PERIPHERAL ARTERY DISEASE WITH AND WITHOUT DIABETES
2020
-
RISK PROFILE AND LONG-TERM PROGNOSIS OF PATIENTS WITH PREMATURE CORONARY ARTERY DISEASE
2020
-
SACUBITRIL-VALSARTAN FOLLOWING HOSPITAL DISCHARGE FOR HEART FAILURE
2020
-
SERUM CYSTATIN C AS MARKER FOR METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN ASYMPTOMATIC PATIENTS
2020
-
TEMPORAL TRENDS IN SEVERITY IN CLINICAL RISK PROFILES AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE
2020
-
HEALTH DISPARITIES IN THE TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA IN PEDIATRIC PATIENTS
2020
-
PREVALENCE OF ASYMPTOMATIC MYOCARDIAL ISCHEMIA IN EXERCISE STRESS ECHOCARDIOGRAPHY
2020
-
Association of MitraClip Availability and Hospital Surgical Mitral Valve Repair Outcomes: An Evaluation of the STS Adult Cardiac Surgical Database
2020
-
BASELINE CHARACTERISTICS FROM THE CARDIOVASCULAR OUTCOMES TRIAL OF OMECAMTIV MECARBIL, GALACTIC-HF (GLOBAL APPROACH TO LOWERING ADVERSE CARDIAC OUTCOMES THROUGH IMPROVING CONTRACTILITY IN HEART FAILURE)
2020
-
CONGESTIVE HEART FAILURE HOSPITALIZATIONS AND COMORBID CANNABIS USE DISORDER: NATIONAL TRENDS AND OUTCOMES (2010-2014)
2020
-
PROFILE OF PATIENTS DISCHARGED AGAINST MEDICAL ADVICE: IS THERE A COST?
2020
-
RACIAL DISPARITIES IN INVASIVE MANAGEMENT FOR PATIENTS WITH CHRONIC KIDNEY DISEASE AND ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM THE CHEST-PAIN MI REGISTRY
2020
-
THE EFFECT OF THE CARDIAC MYOSIN ACTIVATOR, MECAMTIV MECARBIL, ON RIGHT VENTRICULAR STRUCTURE AND FUNCTION IN CHRONIC SYSTOLIC HEART FAILURE (COSMIC-HF)
2020
-
TCT-140 Impact of Left Ventricular Mass Regression on Long-Term Clinical Outcomes After Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER 1 and 2 Trials and Registries
2019
-
TCT-2 Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement in Moderate-Risk Patients: A Pooled PARTNER 2 Trial and Registry Study
2019
-
TCT-4 Transcatheter Tricuspid Valve Repair in Patients With Functional Tricuspid Regurgitation: 2-Year Outcomes From the FORMA US Early Feasibility Study
2019
-
TCT-546 Temporal Trends in Characteristics and Outcomes of Patients With Stable Ischemic Heart Disease Treated With and Without Percutaneous Coronary Intervention
2019
-
TCT-700 Impact of Pulmonary Hypertension and COPD on Outcomes After Transcatheter Aortic Valve Replacement - A Report From the STS/ACC TVT Registry
2019
-
TCT-74 Baseline Left Ventricular Hypertrophy and 5-Year Outcomes after Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER Trials and Registries
2019
-
TCT-743 Comparison of Patient and Clinical Factors Within Echocardiogram Reports to Predict Disparity in Care of Patients With Severe Aortic Stenosis
2019
-
ADULTS AND ADOLESCENTS WITH CONGENITAL HEART DISEASE: WHO ARE WE LOSING TO FOLLOW UP?
2019
-
ANNEXIN A1 A NOVEL BIOMARKER FOR CONGESTION IN ACUTE HEART FAILURE?
2019
-
ANTIPLATELET THERAPY PRESCRIPTION PATTERNS AND ASSOCIATIONS WITH CLINICAL OUTCOMES IN MEDICARE BENEFICIARIES WITH ATRIAL FIBRILLATION PRESCRIBED NO ORAL ANTICOAGULATION AFTER ACUTE ISCHEMIC STROKE
2019
-
ASSESSING THE QUALITY OF REPORTING OF HARMS IN RANDOMIZED CONTROLLED TRIALS PUBLISHED IN HIGH IMPACT CARDIOVASCULAR JOURNALS
2019
-
ASSOCIATION BETWEEN ASSIGNMENT TO AN ACCOUNTABLE CARE ORGANIZATION AND QUALITY OF CARE AND OUTCOMES AMONG MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE
2019
-
ASSOCIATION BETWEEN GUIDELINE-DIRECTED MEDICAL THERAPIES FOR COMORBID CONDITIONS AND CLINICAL OUTCOMES AMONG INDIVIDUALS WITH ATRIAL FIBRILLATION
2019
-
ASSOCIATIONS BETWEEN BETA-BLOCKER THERAPY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIABETES AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM THE TECOS STUDY
2019
-
COGNITIVE FUNCTION AND DEPRESSION IN PATIENTS WITH FIBROMUSCULAR DYSPLASIA
2019
-
COMORBIDITIES AND OUTCOMES IN PATIENTS WITH NON-RHEUMATIC TRICUSPID VALVE DISEASE
2019
-
DIFFERENCES BETWEEN BLACK AND WHITE AMERICANS WITH STABLE CHEST PAIN: ASCVD RISK SCORE, CORONARY ARTERY DISEASE AND CARDIAC EVENTS IN PROMISE (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN)
2019
-
EFFECT OF OMECAMTIV MECARBIL IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE WITH REDUCED EJECTION FRACTION: RESULTS FROM COSMIC-HF
2019
-
IDENTIFYING BIOMARKERS INDEPENDENTLY ASSOCIATED WITH SPONTANEOUS REPERFUSION IN ST ELEVATION MYOCARDIAL INFARCTION
2019
-
IMPACT OF SURGICAL INTERVENTION ON HEALTHCARE UTILIZATION IN PATIENTS WITH NON-RHEUMATIC TRICUSPID VALVE DISEASE
2019
-
IMPACT OF TRICUSPID DISEASE IN PATIENTS WITH CONGESTIVE HEART FAILURE AND MITRAL VALVE DISEASE: A NATIONWIDE COHORT STUDY
2019
-
INCREASED RISK OF SEVERE HYPOGLYCEMIC EVENTS BEFORE AND AFTER CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: VALIDATION OF A NOVEL CONCEPT
2019
-
LONGITUDINAL CHANGES IN MEDICATION DOSING AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: FROM THE CHAMP-HF REGISTRY
2019
-
LOW RATES OF ORAL ANTICOAGULATION USE AND POOR OUTCOMES AMONG FRAIL PATIENTS HOSPITALIZED WITH ATRIAL FIBRILLATION
2019
-
MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL)
2019
-
OUTCOMES ASSOCIATED WITH DIFFERENT TREATMENT PATTERNS AMONG PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE AND REDUCED EJECTION FRACTION IN THE UNITED STATES
2019
-
OUTCOMES OF NON-SURGICAL PATIENTS WITH SEVERE TRICUSPID REGURGITATION AND CONGESTIVE HEART FAILURE
2019
-
PARADOXICAL PROTECTIVE EFFECT OF OBESITY ON THE RISK OF VENOUS THROMBOEMBOLISM: OBSERVATIONS FROM APEX TRIAL
2019
-
PATIENTS WITH DIABETES AND PERIPHERAL ARTERIAL DISEASE: RESULTS FROM THE EXSCEL TRIAL
2019
-
PRE- VERSUS POST-PROCEDURE CLINICAL EVENT RATES AND ASSOCIATED HEALTHCARE RESOURCE UTILIZATION IN PATIENTS UNDERGOING COMMERCIAL MITRACLIP PLACEMENT
2019
-
PROGNOSTIC IMPLICATIONS OF BLUNTED FEATURE TRACKING GLOBAL LONGITUDINAL STRAIN DURING CARDIOVASCULAR MAGNETIC RESONANCE (CMR) STRESS IMAGING
2019
-
PROVIDER PERSPECTIVES ON THE FEASIBILITY AND UTILITY OF ROUTINE PATIENT-REPORTED OUTCOMES ASSESSMENT IN HEART FAILURE: A QUALITATIVE ANALYSIS
2019
-
PROVIDER-LEVEL VARIABILITY IN THE TREATMENT OF PATIENTS WITH SEVERE SYMPTOMATIC AORTIC VALVE STENOSIS
2019
-
RACE AND SEX-BASED DISPARITIES PERSIST IN THE TREATMENT OF PATIENTS WITH SEVERE, SYMPTOMATIC AORTIC VALVE STENOSIS
2019
-
SEX-BASED DIFFERENCES IN OUTCOMES AFTER TRANSCATHETER REPAIR OF MITRAL REGURGITATION WITH THE MITRALCLIP SYSTEM
2019
-
SOLUBLE NEPRILYSIN IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
2019
-
STATIN THERAPY IN PATIENTS WITH CEREBROVASCULAR DISEASE VERSUS CORONARY ARTERY DISEASE: INSIGHTS FROM THE PALM REGISTRY
2019
-
STRESS CMR IN ABNORMAL LVEF: CLINICAL IMPACT AND COST EFFECTIVENESS
2019
-
TRANSFUSIONS, WITH OR WITHOUT CONCOMITANT BLEEDING, ARE ASSOCIATED WITH HIGH SHORT-TERM MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ORAL ANTICOAGULATION
2019
-
TREATMENT PATTERNS AND OUTCOMES AMONG MEDICARE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION (NVAF) AND CHRONIC KIDNEY DISEASE
2019
-
TRENDS IN RACIAL DIFFERENCES IN 30-DAY READMISSION RATE FOR ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS FROM THE NCDR CHEST PAIN-MI REGISTRY
2019
-
USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF
2019
-
VOLUME OVERLOAD FROM MITRAL OR AORTIC REGURGITATION RESULTS IN FURTHER LV REMODELING IN AORTIC STENOSIS
2019
-
GW29-e0593 Association of Depression and Unhealthy Lifestyle Behaviors in Chinese Patients with Acute Coronary Syndromes
2018
-
TCT-45 Quality of Life Outcomes after Transcatheter Mitral Valve Repair in an Unselected Population. A Report from the STS/ACC TVT RegistryTM
2018
-
TCT-453 Appropriateness of Transcatheter Aortic Valve Replacement: Insight from the OCEAN-TAVI Registry
2018
-
TCT-46 Mitral Valve Gradient, Heart Failure Admissions and One Year Mortality Following MitraClip Repair in 5,378 Patients: Results from the ACC/STS TVT Registry
2018
-
TCT-7 Predictors and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement
2018
-
TCT-70 Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.
2018
-
TCT-775 A Systematic Review of Randomized and Non-randomized Studies Comparing Dual Therapy with Triple Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
2018
-
TCT-802 Effects of Pulmonary Hypertension on Transcatheter Mitral Valve Repair Outcomes: Analysis of The STS/ACC TVT Registry
2018
-
IMPACT OF A MULTIFACETED EDUCATIONAL INTERVENTION ON ORAL ANTICOAGULATION (OAC) USE IN ATRIAL FIBRILLATION (AF) PATIENTS ACCORDING TO ASPIRIN USE AT BASELINE: INSIGHTS FROM IMPACT-AF TRIAL
2018
-
AORTIC VALVE REPLACEMENT AND OUTCOMES IN PATIENTS WITH SEVERE AORTIC STENOSIS: IS IT BLACK OR WHITE?
2018
-
ATRIAL FIBRILLATION IS ASSOCIATED WITH HIGHER RATES OF DEATH AND HEART FAILURE HOSPITALIZATIONS IN PATIENTS UNDERGOING MITRACLIP: OUTCOMES FROM THE TVT REGISTRY
2018
-
ATRIAL ISCHEMIA AS A MECHANISM OF ATRIAL FIBRILLATION
2018
-
CHARACTERISTICS OF CARDIAC ARREST AND BYSTANDER RESUSCITATION WITHIN OUTPATIENT DIALYSIS CLINICS IN NORTH CAROLINA
2018
-
CHOOSING CARDIOLOGY: CAREER CHOICE AND GENDER INFLUENCE PROFESSIONAL DEVELOPMENT NEEDS AND PERCEPTIONS OF THE CARDIOLOGY FIELD AMONG INTERNAL MEDICINE TRAINEES
2018
-
CO-MORBIDITIES AND ETHNICITY/RACE PREDICT MORBIDITY AND MORTALITY IN HIGH RISK HEART FAILURE PATIENTS WITH SYSTOLIC DYSFUNCTION: THE GUIDE-IT PREDICTIVE RISK MODEL
2018
-
CYP2C19 STATUS AND OUTCOMES IN THE EUCLID TRIAL
2018
-
EARLY IMPACT OF GUIDELINE PUBLICATION ON ANGIOTENSIN-RECEPTOR NEPRILYSIN INHIBITOR USE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE
2018
-
ECHOCARDIOGRAPHIC MEASUREMENT OF CARDIAC TWIST: A SYSTEMATIC REVIEW AND META-ANALYSIS
2018
-
ELECTRONIC HEALTH RECORD ALGORITHMS TO DETECT PAD
2018
-
EVALUATING SAFETY AND VENTRICULAR SYSTOLIC FUNCTION AFTER AUTOLOGOUS CORD BLOOD ADMINISTRATION IN NEONATES WITH HYPOPLASTIC LEFT HEART SYNDROME
2018
-
GLOBAL RANK ENDPOINT USING NT-PROBNP VERSUS 6 MINUTE WALK DISTANCE IN HF PATIENTS: ANALYSIS FROM THE CAT-HF TRIAL
2018
-
HIGH HOSPITAL VARIABILITY IN MORTALITY AFTER TAVR CAN BE EXPLAINED BY DIFFERENCES IN FAILURE TO RESCUE FROM POST PROCEDURAL COMPLICATIONS
2018
-
IMPACT OF POST-OPERATIVE ATRIAL FIBRILLATION ON EARLY AND LATE OUTCOMES AFTER PROXIMAL AORTIC SURGERY
2018
-
IMPACT OF PULMONARY HYPERTENSION ON SURVIVAL FOLLOWING DEVICE CLOSURE OF ATRIAL SEPTAL DEFECT IS LIMITED BY AGE
2018
-
INCREASED CLINICAL AND FINANCIAL BURDEN OF HEART FAILURE HOSPITALIZATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE
2018
-
MAJOR BLEEDING IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: INSIGHTS FROM THE EUCLID TRIAL
2018
-
OUTCOME OF LUNG DISEASE-RELATED PULMONARY HYPERTENSION AND IMPACT OF VASOREACTIVITY
2018
-
OUTCOMES AFTER TRANSCATHETER MITRAL VALVE REPAIR IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN ANALYSIS OF 5,241 PATIENTS IN THE UNITED STATES
2018
-
OUTCOMES FOLLOWING URGENT/EMERGENT TRANSCATHETER AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE STS/ACC TVT REGISTRY
2018
-
OUTCOMES OF CARDIAC CATH/PCI IN PATIENTS WITH AF: INSIGHTS FROM THE ORBIT II REGISTRY
2018
-
OVERALL AND SEX-SPECIFIC REFERENCE RANGES FOR HIGH-SENSITIVITY TROPONIN T GEN 5 STAT IN THE UNITED STATES
2018
-
PATIENT SELECTION FOR DE-NOVO LEADLESS SINGLE-CHAMBER VENTRICULAR PACING: RESULTS FROM THE MICRA TRANSCATHETER PACING STUDY
2018
-
PHYSICAL FUNCTION, QUALITY OF LIFE, AND DEPRESSION IN ELDERLY, HOSPITALIZED PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE WITH PRESERVED VERSUS REDUCED EJECTION FRACTION: ANALYSIS FROM THE REHAB-HF TRIAL
2018
-
PHYSICIAN JUDGMENT MORE ACCURATE THAN DIAMOND-FORRESTER RISK SCORE IN PREDICTING OBSTRUCTIVE CAD AND ADVERSE CARDIAC EVENTS IN PATIENTS WITH CHEST PAIN: INSIGHTS FROM THE PROMISE TRIAL
2018
-
POPULATION-SPECIFIC GENETIC VARIATIONS INCREASE HAZARD OF MORTALITY OR REHOSPITALIZATION IN HEART FAILURE PATIENTS
2018
-
PREDICTORS OF 30-DAY READMISSION IN PATIENTS WITH SYNCOPE
2018
-
PRIOR HEART FAILURE HOSPITALIZATION AMONG PATIENTS HOSPITALIZED FOR WORSENING CHRONIC HEART FAILURE: FROM THE ASCEND-HF TRIAL
2018
-
SYSTEMATIC REVIEW OF PREVALENT AND INCIDENT HEART FAILURE IN CARDIOVASCULAR OUTCOME TRIALS OF PATIENTS WITH TYPE 2 DIABETES
2018
-
THE EFFECT AND RELATIONSHIP OF AGE AND FRAILTY ON SURVIVAL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
2018
-
THE EFFICACY AND SAFETY OF APIXABAN VERSUS WARFARIN ARE PRESERVED IN PATIENTS WITH ATRIAL FIBRILLATION AND EXTREMELY HIGH BODY WEIGHT: INSIGHTS FROM THE ARISTOTLE STUDY
2018
-
UNDETERMINED CAUSE OF DEATH: A POOLED ANALYSIS OF 9,307 DEATHS ACROSS 9 CARDIOVASCULAR TRIALS
2018
-
GW28-e0140 Knockout of Small Ubiquitin-Like Modifier 1 Protects the Mice from Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction
2017
-
TCT-339 Types of Myocardial Infarction in Patients with Peripheral Artery Disease: Insights From EUCLID
2017
-
TCT-384 The Myocardial Contraction Fraction Predicts Adverse Events after Aortic Valve Replacement: An Analysis of 3,259 Patients from the Pooled PARTNER 2 Database
2017
-
TCT-421 Prevalence and treatment patterns for in-stent restenosis: A single center report from the Duke Databank for Cardiovascular Disease
2017
-
TCT-51 Impact of anticoagulation therapy on valve hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: A pooled analysis of the PARTNER2 trials
2017
-
TCT-768 Risk Adjustment Model for 30-Day Mortality After Transcatheter Aortic Valve Replacement. A Report from the STS/ACC TVT RegistryTM
2017
-
TCT-92 Polyvascular Disease and Risk of Major Cardiovascular Events in Peripheral Artery Disease—Insights from EUCLID
2017
-
A HOSPITAL LEVEL ANALYSIS OF 30-DAY READMISSION RATES FOR HEART FAILURE PATIENTS AND LONG-TERM SURVIVAL AMONG HIGHEST AND LOWEST PERFORMING HOSPITALS, FINDINGS FROM GET WITH THE GUIDELINES-HEART FAILURE
2017
-
ALTERNATING BUNDLE BRANCH BLOCK: CLINICAL CONSIDERATIONS
2017
-
CLOPIDOGREL IS NOT COMMONLY USED BUT ASSOCIATED WITH LESS RE-HOSPITALIZATION IN PATIENTS WITH PERIOPERATIVE MYOCARDIAL INFARCTION FOLLOWING CABG SURGERY
2017
-
DIRECT HOME DISCHARGE AND LIKELIHOOD OF 30-DAY HOSPITAL READMISSION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR): FINDINGS FROM THE STS/ACC TVT REGISTRY
2017
-
DUAL ANTIPLATELET THERAPY UTILIZATION AND CARDIOVASCULAR OUTCOMES AMONG BLACK AND WHITE PATIENTS TREATED WITH DRUG ELUTING STENTS
2017
-
EARLY DEFIBRILLATION BY FIRST-RESPONDERS IN RELATION TO FIRE STATIONS: OPTIMAL BENEFIT ACCORDING TO LOCATION
2017
-
ECHOCARDIOGRAPHIC PREDICTORS FOR IN-HOSPITAL AND 1-YEAR OUTCOMES IN LEFT-SIDED INFECTIVE ENDOCARDITIS: AN ANALYSIS FROM THE INTERNATIONAL COLLABORATION ON ENDOCARDITIS-PROSPECTIVE ECHO COHORT STUDY
2017
-
EFFECT OF OBESITY AND UNDERWEIGHT STATUS ON PERIOPERATIVE OUTCOMES IN PATIENTS WITH CONGENITAL HEART DISEASE: AN ANALYSIS OF DATA FROM THE SOCIETY OF THORACIC SURGEONS CONGENITAL HEART SURGERY DATABASE
2017
-
EFFECTS OF AGE AND COMORBIDITIES ON OUTCOMES IN PATIENTS WITH HEART FAILURE FROM HF-ACTION
2017
-
HEART FAILURE WITH REDUCED EJECTION FRACTION CARE PATTERNS IN THE OUTPATIENT PRACTICE SETTING: INITIAL FINDINGS FROM CHAMP-HF
2017
-
HEART RATE RESPONSE DURING REGADENOSON STRESS CARDIAC MAGNETIC RESONANCE IMAGING IS A PREDICTOR OF ADVERSE CARDIOVASCULAR OUTCOMES
2017
-
HEMOCONCENTRATION DURING MANAGEMENT OF PATIENTS WITH ACUTE HEART FAILURE AND CARDIORENAL SYNDROME: INSIGHTS FROM CARRESS-HF
2017
-
HYPERTHYROIDISM INCREASES THE RISK OF TAKOTSUBO CARDIOMYOPATHY AMONG HOSPITALIZED U.S. PATIENTS
2017
-
IMPACT OF THE PRESENCE OF CORONARY ARTERY DISEASE AND TIMING OF REVASCULARIZATION ON OUTCOMES OF PATIENTS UNDERGOING TRANS-CATHETER AORTIC VALVE REPLACEMENT: INSIGHTS FROM STS/ACC TVT REGISTRY
2017
-
IMPROVEMENT IN CHOLESTEROL EFFLUX CAPACITY IS ASSOCIATED WITH A REDUCTION IN AORTIC WALL THICKNESS BY MRI INDEPENDENT OF TRADITIONAL CV RISK FACTORS
2017
-
INCIDENCE AND OUTCOMES OF PATIENTS REQUIRING SURGICAL BAIL-OUT DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: A REPORT FROM THE NCDR® STS/ACC TRANSCATHETER VALVE THERAPY (TVT) REGISTRY
2017
-
INFLUENCE OF SEX ON PLATELET RESPONSE TO ASPIRIN AND TICAGRELOR
2017
-
LOW UTILIZATION OF SURGICAL INTERVENTION TO TREAT SEVERE AORTIC STENOSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
2017
-
NEW-ONSET ATRIAL FIBRILLATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: INCIDENCE, ANTICOAGULANT STRATEGY, AND OUTCOMES
2017
-
NUISANCE BLEEDING IN ANTICOAGULATED PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE OUTCOMES REGISTRY FOR BETTER INFORMED TREATMENT OF ATRIAL FIBRILLATION (ORBIT-AF)
2017
-
OUTCOMES OF THE DIFFERENT FLOW/GRADIENT PATTERNS OF AORTIC STENOSIS AFTER AORTIC VALVE REPLACEMENT: INSIGHTS FROM PARTNER 2A TRIAL
2017
-
PATTERNS OF RED BLOOD CELL TRANSFUSION AND ASSOCIATED OUTCOMES IN PATIENTS UNDERGOING TAVR: INSIGHTS FOR THE STS/ACC TVT REGISTRY
2017
-
PERIPHERAL ARTERY DISEASE AND TRANSCATHETER AORTIC VALVE REPLACEMENT OUTCOMES: A REPORT FROM THE STS/TVT REGISTRY
2017
-
PREDICTORS OF MORTALITY AFTER TAVR IN A “REAL WORLD” SETTING
2017
-
PREVALENCE AND OUTCOMES OF MITRAL STENOSIS IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FINDINGS FROM THE SOCIETY OF THORACIC SURGEONS/AMERICAN COLLEGE OF CARDIOLOGY (STS/ACC) TRANSCATHETER VALVE THERAPIES (TVT) REGISTRY
2017
-
PREVALENT DIGOXIN USE IS NOT ASSOCIATED WITH INCREASED RISK OF DEATH OR HOSPITALIZATION IN AMBULATORY HEART FAILURE PATIENTS WITH A REDUCED EJECTION FRACTION
2017
-
PULMONARY VASCULAR RESPONSE TO NITRIC OXIDE AND SUBSEQUENT RESPONSE TO ADVANCED MEDICAL THERAPY IN INCIDENT PATIENTS WITH PULMONARY HYPERTENSION
2017
-
RATIONALE AND METHODS OF THE PROSPECTIVE STUDY OF BIOMARKERS, SYMPTOM IMPROVEMENT AND VENTRICULAR REMODELING DURING ENTRESTO THERAPY FOR HEART FAILURE (PROVE-HF) STUDY
2017
-
STROKE AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CAROTID DISEASE UNDERGOING TAVR: INSIGHTS FROM THE STS/TVT REGISTRY
2017
-
SURGERY FOR PATIENTS WITH BICUSPID AORTOPATHY: VALIDATION OF THE 2016 ACC/AHA GUIDELINES CLARIFICATION
2017
-
SURGICAL RISK SCORES OUTWEIGH ECHOCARDIOGRAPHIC SEVERITY OF AORTIC STENOSIS FOR DETERMINING PROGNOSIS IN PATIENTS WITH LOW GRADIENT SEVERE AORTIC STENOSIS AND PRESERVED LEFT VENTRICULAR FUNCTION
2017
-
SURROGATE ENDPOINTS AND THE DIFFERENTIAL RESPONSE TO ASV FOR SLEEP APNEA IN HFREF VERSUS HFPEF IN THE CAT-HF TRIAL
2017
-
THE CARDIAC MYOSIN ACTIVATOR, OMECAMTIV MECARBIL, IMPROVES LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN CHRONIC HEART FAILURE (COSMIC-HF)
2017
-
THE EFFECT OF RACE ON THE ANTIPLATELET EFFECTS OF TICAGRELOR AND ASPIRIN
2017
-
THE IMPACT OF THE CURRENT VERSUS PRIOR CARDIAC RESYNCHRONIZATION GUIDELINES ON THE PROPORTION OF HOSPITALIZED HEART FAILURE PATIENTS ELIGIBLE FOR THERAPY
2017
-
THE ROLE OF BASELINE VERSUS LONG-TERM FOLLOW-UP EJECTION FRACTION IN PREDICTING ADVERSE EVENTS AMONG PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATOR RECIPIENTS
2017
-
TIME OF PRESENTATION AMONG PATIENTS HOSPITALIZED FOR ACUTE HEART FAILURE (CLINICAL CHARACTERISTICS, INITIAL THERAPIES AND OUTCOMES): INSIGHTS FROM ASCEND-HF
2017
-
TIMING AND CLINICAL PREDICTORS OF EARLY VERSUS LATE READMISSION AMONG PATIENTS HOSPITALIZED FOR ACUTE HEART FAILURE: INSIGHTS FROM ASCEND-HF
2017
-
UNIVERSAL USE OF CONTRAST TO DETECT LEFT VENTRICULAR THROMBUS IN PATIENTS WITH REDUCED EJECTION FRACTION IS NOT ASSOCIATED WITH IMPROVED CLINICAL OR COST-EFFECTIVENESS OUTCOMES
2017
-
TCT-38 Paravalvular Regurgitation Regression and Impact on 1-year Outcomes After Transcatheter Aortic Valve Replacement with the SAPIEN 3 Transcatheter Valve
2016
-
TCT-674 Sex Specific Outcomes of TAVR with the Sapien 3 Valve: Insights From The PARTNER 2 S3 High-Risk and Intermediate-Risk Cohorts
2016
-
TCT-679 Diabetes and Clinical Outcomes in Intermediate Risk Patients Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: An Analysis of the PARTNER 2A Trial
2016
-
TCT-699 Anatomic Deployment Index: A Novel Measure of SAPIEN 3 Transcatheter Heart Valve Performance
2016
-
AEROBIC EXERCISE TRAINING AND HEALTH STATUS IN AMBULATORY HEART FAILURE PATIENTS WITH A REDUCED EJECTION FRACTION: AN ANALYSIS FROM THE HF-ACTION TRIAL
2016
-
ALTERATIONS IN PHOSPHODIESTERASE 5 EXPRESSION AND β-ADRENERGIC RESPONSE IN THE HUMAN VOLUME-OVERLOADED RIGHT VENTRICLE
2016
-
AN AGE- AND SEX-SPECIFIC PERIPHERAL BLOOD GENE EXPRESSION SCORE CORRELATES WITH FUTURE CARDIOVASCULAR EVENTS: INSIGHTS FROM THE PROMISE TRIAL
2016
-
AORTIC VASCULAR INFLAMMATION BY 18-FDG PET/MRI IS RELATED TO CORONARY PLAQUE BURDEN BY QUANTITATIVE CORONARY CT ANGIOGRAPHY IN PSORIASIS
2016
-
ASPIRIN DOSING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH TICAGRELOR: INSIGHT FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY (NCDR)
2016
-
ASSOCIATION BETWEEN PRE-CATHETERIZATION USE OF P2Y12 INHIBITORS WITH TIMING OF CABG AND CABG-RELATED OUTCOMES IN PATIENTS PRESENTING WITH NSTEMI AND SURGICAL CORONARY DISEASE: INSIGHTS FROM NCDR ®
2016
-
ASSOCIATION OF ACUTE MYOCARDIAL INFARCTION CARDIAC ARREST PATIENT VOLUME AND IN-HOSPITAL MORTALITY
2016
-
CLINICAL AND ECHOCARDIOGRAPHIC PREDICTORS OF EXERCISE CAPACITY FOLLOWING MITRAL VALVE SURGERY FOR MITRAL REGURGITATION
2016
-
CLINICAL IMPACT OF OUTPATIENT STRESS CARDIAC MAGNETIC RESONANCE (CMR) IMAGING IS INDEPENDENT OF APPROPRIATE USE CRITERIA
2016
-
DETERMINANTS OF VASCULAR INFLAMMATION BY 18-FLUORODEOXYGLUCOSE PET/MRI: FINDINGS FROM THE PSORIASIS, ATHEROSCLEROSIS AND CARDIOMETABOLIC DISEASE INITIATIVE
2016
-
DIAGNOSIS OF PULMONIC VALVE INFECTIVE ENDOCARDITIS WITH THE USE OF POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY SCAN
2016
-
DUAL ANTIPLATELET THERAPY PRIOR TO CABG
2016
-
EFFECTS OF A NOVEL TETRAPEPTIDE IN HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF): A PHASE I RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ELAMIPRETIDE
2016
-
EVALUATION OF MEDICATION PERSISTENCE IN THE IMPROVE-IT TRIAL
2016
-
HOSPITAL-LEVEL VARIATION IN THE USE OF EARLY CATHETERIZATION FOR PATIENTS WITH NON-ST ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE NCDR ACTION REGISTRY-GWTG
2016
-
IDENTIFYING STABLE CHEST PAIN PATIENTS WITH SUSPECTED CORONARY DISEASE IN WHOM NONINVASIVE TESTING MAY BE SAFELY DEFERRED: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN)
2016
-
IMPACT OF DEVICE TYPE ON RESIDUAL SHUNT FOLLOWING PERCUTANEOUS ATRIAL SEPTAL DEFECT CLOSURE
2016
-
IMPACT OF REGIONAL SYSTEMS OF CARE ON DISPARITIES OF CARE IN FEMALES AND BLACKS PRESENTING WITH ST ELEVATION MYOCARDIAL INFARCTION
2016
-
IMPROVEMENT IN PSORIASIS SKIN DISEASE SEVERITY IS ASSOCIATED WITH REDUCTION OF CORONARY PLAQUE BURDEN
2016
-
IN-HOSPITAL MORTALITY OF MYOCARDIAL INFARCTION BY SEX, AGE, AND OBSTRUCTIVE CORONARY ARTERY DISEASE STATUS IN THE ACTION REGISTRY-GWTG
2016
-
INFLUENCE OF CLINICAL TRIAL SITE ENROLLMENT ON PATIENT CHARACTERISTICS, PROTOCOL COMPLETION, AND ENDPOINTS: INSIGHTS FROM THE ASCEND-HF TRIAL
2016
-
INTENSIVE CARE UNIT AMONG MEDICARE PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
2016
-
IS ATRIAL FIBRILLATION IMPORTANT FOR LOW GRADIENT SEVERE AORTIC STENOSIS WITH PRESERVED EJECTION FRACTION?
2016
-
LEFT VENTRICULAR LONGITUDINAL FUNCTION ASSESSED WITH CARDIAC MAGNETIC RESONANCE IMAGING EFFECTIVELY RECLASSIFIES PATIENT RISK BEYOND CLINICAL VARIABLES
2016
-
LONG-TERM OUTCOMES OF AN FFRCT DIAGNOSTIC STRATEGY VERSUS USUAL CARE IN SUSPECTED CORONARY ARTERY DISEASE: RESULTS FROM THE PLATFORM (PROSPECTIVE LONGITUDINAL TRIAL OF FFRCT: OUTCOME AND RESOURCE IMPACTS) STUDY
2016
-
LOW USE OF ORAL ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION AND RISK FOR STROKE IN THE UNITED STATES
2016
-
MANAGEMENT AND OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND CANCER: THE ORBIT-AF REGISTRY
2016
-
MENTAL STRESS-INDUCED PLATELET AGGREGATION PREDICTS ADVERSE CARDIOVASCULAR OUTCOME IN ISCHEMIC HEART DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
2016
-
MORTALITY FOLLOWING INITIATION OR DISCONTINUATION OF GUIDELINE DIRECTED MEDICAL THERAPIES IN HOSPITALIZED HEART FAILURE PATIENTS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
2016
-
ORAL ANTICOAGULANT SELECTION IN COMMUNITY PATIENTS WITH NEW-ONSET ATRIAL FIBRILLATION: RESULTS FROM THE ORBIT-AF II REGISTRY
2016
-
OUTCOMES OF PERMANENT PACEMAKER IMPLANTATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: ANALYSIS OF THE STS/ACC TVT REGISTRYTM
2016
-
PATTERNS OF PREVENTIVE MEDICAL THERAPY AND LIFESTYLE PRACTICES IN PATIENTS EVALUATED FOR SUSPECTED CORONARY ARTERY DISEASE: THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN)
2016
-
PROGNOSTIC VALUE OF RIGHT-SIDED VOLUME OVERLOAD IN PATIENTS PRESENTING WITH ACUTE HEART FAILURE: INSIGHTS FROM ASCEND-HF
2016
-
PULMONARY HYPERTENSION IS ASSOCIATED WITH WORSE TAVR OUTCOMES INDEPENDENT OF COPD: REPORT FROM THE TVT REGISTRY
2016
-
SEX DIFFERENCES IN DEMOGRAPHICS, RISK FACTORS AND PRESENTATION IN STABLE CONTEMPORARY OUTPATIENTS WITH SUSPECTED CORONARY ARTERY DISEASE: INSIGHTS FROM THE PROMISE TRIAL
2016
-
SEX DIFFERENCES IN LONG-TERM OUTCOMES OF PATIENTS WITH NON-OBSTRUCTIVE CORONARY ARTERY DISEASE
2016
-
SMALL DENSE LOW-DENSITY LIPOPROTEIN (LDL) PARTICLE NUMBER PREDICTS VASCULAR INFLAMMATION INDEPENDENT OF TRADITIONAL LIPID CARDIOVASCULAR RISK FACTORS IN PSORIASIS
2016
-
STATEWIDE INITIATIVES IMPROVE THE CARE AND OUTCOMES OF PATIENTS WITH OUT-OF-HOSPITAL CARDIAC ARREST AT HOME AND IN PUBLIC LOCATIONS: RESULTS FROM THE HEARTRESCUE PROJECT
2016
-
TEMPORAL TRENDS AND REGIONAL PATTERNS OF OPERATOR PERCUTANEOUS CORONARY INTERVENTION VOLUME IN THE UNITED STATES: A REPORT FROM THE NCDR CATHPCI REGISTRY
2016
-
THE ASSOCIATION OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WITH LONG-TERM ADVERSE EVENTS AMONG PATIENTS WITH ESTABLISHED CORONARY ARTERY DISEASE: INSIGHTS FROM THE IMPROVE-IT TRIAL
2016
-
THE RELATIONSHIP BETWEEN BODY WEIGHT CHANGE DURING HOSPITALIZATION FOR ACUTE HEART FAILURE AND PATIENT CHARACTERISTICS, MARKERS OF CONGESTION, AND OUTCOMES: FINDINGS FROM ASCEND-HF
2016
-
THE ROLE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS) IN PATIENTS WITH A LEFT VENTRICULAR ASSIST DEVICE (LVAD): A SYSTEMATIC REVIEW AND META-ANALYSIS
2016
-
TRANSCATHETER AORTIC VALVE REPLACEMENT IS ASSOCIATED WITH FEWER HOSPITAL DAYS: A REPORT FROM THE STS/ACC TVT REGISTRY
2016
-
TREATMENT AND STROKE RISK IN LOW RISK CHA2DS2VASC ATRIAL FIBRILLATION PATIENTS: FINDINGS FROM THE ORBIT-AF REGISTRY
2016
-
UTILIZATION, CHARACTERISTICS, AND IN-HOSPITAL OUTCOMES FOR PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING IN-HOSPITAL CORONARY ARTERY BYPASS GRAFTING (CABG)
2016
-
VALIDATION OF THE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) POOLED COHORT RISK EQUATIONS BY EDUCATION LEVEL: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
2016
-
TCT-103 National variation in post-TAVR antithrombotic therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry®
2015
-
TCT-111 Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: Insights from the US TVT National Registry
2015
-
TCT-284 Comparison of Visual Assessment of Coronary Stenosis with Independent Quantitative Coronary Angiography: Findings from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain)
2015
-
TCT-618 Outcomes of TAVR in Nonagenarians in the U.S.: Insights from the STS/ACC TVT Registry
2015
-
TCT-94 Balloon Post-Dilation of the Self-Expanding CoreValve Transcatheter Aortic Valve Bioprosthesis: Procedural Results and In Hospital Outcomes from 3532 patients in the CoreValve US Pivotal and Continued Access Trials
2015
-
TCT-95 The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement: A Report from the PARTNER I Trial
2015
-
ADRENERGIC RECEPTOR POLYMORPHISMS INTERACT WITH BETA-BLOCKER DOSE EFFECT ON HEART FAILURE OUTCOMES ESPECIALLY IN BLACK RACE: RESULTS FROM HF-ACTION DNA SUBSTUDY
2015
-
ALPHA-2C ADRENERGIC RECEPTOR POLYMORPHISM INTERACTS WITH BETA-BLOCKER DOSE EFFECT ON HEART FAILURE OUTCOMES DIFFERENTLY IN BLACK RACE: RESULTS FROM THE HF-ACTION DNA SUBSTUDY
2015
-
ANTI-HYPERGLYCEMIC MEDICATION USE AMONG MEDICARE BENEFICIARIES WITH HEART FAILURE, DIABETES, AND CHRONIC KIDNEY DISEASE
2015
-
APIXABAN FOLLOWING ACUTE CORONARY SYNDROMES AMONG PATIENTS WITH PRIOR STROKE: INSIGHTS FROM THE APPRAISE-2 TRIAL
2015
-
ARE THERE DIFFERENCES IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR COUNSELING RATES AMONG ELIGIBLE PATIENTS HOSPITALIZED FOR HEART FAILURE? NATIONAL RESULTS FROM THE AMERICAN HEART ASSOCIATION’S GET WITH THE GUIDELINES- HEART FAILURE PROGRAM
2015
-
ASSOCIATION OF DISEASE-SPECIFIC HEALTH STATUS WITH LONG-TERM MORTALITY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
2015
-
BLOOD PRESSURE AND RISK FOR STROKE OR BLEEDING EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM THE ORBIT AF STUDY
2015
-
BR2ACED RISK SCORE A PREDICTOR OF MORTALITY PRIOR TO TAVR
2015
-
CALCULATION OF LEFT VENTRICULAR STROKE VOLUME BY DOPPLER ECHOCARDIOGRAPHY: IS ONE METHOD BETTER THAN THE OTHER?
2015
-
CARDIAC-CYCLE RELATED CHANGES IN TRABECULATED LEFT VENTRICULAR VOLUME IN CARDIAC MAGNETIC RESONANCE IMAGING
2015
-
COMPARATIVE EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY WITH DEFIBRILLATOR VERSUS DEFIBRILLATOR ALONE IN HEART FAILURE PATIENTS WITH MODERATE TO SEVERE CHRONIC KIDNEY DISEASE
2015
-
CORONARY ARTERY CALCIUM SCORE AND CARDIOVASCULAR RISK RECLASSIFICATION
2015
-
DIURETIC RESPONSE IN ACUTE HEART FAILURE: AN ANALYSIS FROM ASCEND-HF
2015
-
DOES BASELINE GLOBAL LONGITUDINAL STRAIN PREDICT MORTALITY IN HIGH RISK PATIENTS WITH AORTIC STENOSIS AND LEFT VENTRICULAR DYSFUNCTION?
2015
-
ECHOCARDIOGRAPHY CORE LAB REPRODUCIBILITY OF CARDIAC SAFETY ASSESSMENTS IN CARDIO-ONCOLOGY
2015
-
ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
2015
-
ETHNICITY, CORONARY ARTERY CALCIUM SCORE AND CARDIOVASCULAR RISK RECLASSIFICATION
2015
-
GENDER, CORONARY ARTERY CALCIUM SCORE AND CARDIOVASCULAR RISK RECLASSIFICATION
2015
-
GLYCA, A NOVEL BIOMARKER OF SYSTEMIC INFLAMMATION, IMPROVES CARDIOVASCULAR RISK PREDICTION IN A HIGH-RISK CORONARY CATHETERIZATION COHORT
2015
-
HAS PUBLIC REPORTING OF READMISSIONS IMPROVED CARE FOR PATIENTS WITH HEART FAILURE?
2015
-
IMPACT OF DIASTOLIC DYSFUNCTION ON POST-OPERATIVE OUTCOMES AFTER CARDIAC SURGERY: A META-ANALYSIS
2015
-
IMPACT OF PERSISTENT RIGHT TO LEFT SHUNT IN DEVICE-OCCLUDED ATRIAL SEPTAL DEFECTS
2015
-
IMPACT OF PULMONARY HYPERTENSION ON RIGHT HEART REMODELING FOLLOWING DEVICE CLOSURE OF ATRIAL SEPTAL DEFECTS
2015
-
INITIAL RESULTS FROM THE CASCADE-FH REGISTRY: CASCADE SCREENING FOR AWARENESS AND DETECTION OF FAMILIAL HYPERCHOLESTEROLEMIA
2015
-
INTERLEUKIN-6 IS ASSOCIATED WITH, BUT DOES NOT INDEPENDENTLY PREDICT, MORTALITY IN ACUTE HEART FAILURE: AN ASCEND-HF SUBSTUDY
2015
-
Metabolomic Profiling Identifies Biomarkers Predicting Adverse Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
2015
-
Metabolomic Profiling Identifies Biomarkers of Mitochondrial Function in Heart Failure with Preserved versus Reduced Ejection Fraction
2015
-
NATIONAL PATTERNS IN INTENSITY OF OUTPATIENT CARE FOR APPARENT TREATMENT RESISTANT HYPERTENSION
2015
-
OUTCOMES FOLLOWING URGENT OR EMERGENT CORONARY ARTERY BYPASS GRAFTING IN PATIENTS WITH CARDIOGENIC SHOCK AND AN UNRESPONSIVE PRE-OPERATIVE NEUROLOGIC STATE
2015
-
PATIENT-REPORTED SYMPTOMS AND REVASCULARIZATION STATUS AFTER CORONARY ARTERY BYPASS GRAFT SURGERY IN DIABETICS AND NON-DIABETICS
2015
-
PLASMA ENDOTHELIN-1 INDEPENDENTLY PREDICTS 180-DAY MORTALITY IN ACUTE HEART FAILURE: AN ASCEND-HF SUB-STUDY
2015
-
PROGNOSTIC VALUE OF BASELINE AND CHANGES IN CIRCULATING SOLUBLE ST2 LEVELS AND THE EFFECTS OF NESIRITIDE IN ACUTE DECOMPENSATED HEART FAILURE
2015
-
RACE AND SEX DIFFERENCES IN THE QRS INTERVAL AMONG PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
2015
-
RACIAL DIFFERENCES IN LEFT VENTRICULAR TRABECULATIONS BY CARDIAC MAGNETIC RESONANCE IMAGING
2015
-
RACIAL/ETHNIC DIFFERENCES IN ATRIAL FIBRILLATION SYMPTOMS, TREATMENT PATTERNS, AND OUTCOMES: INSIGHTS FROM OUTCOMES REGISTRY FOR BETTER INFORMED TREATMENT FOR ATRIAL FIBRILLATION (ORBIT-AF) REGISTRY
2015
-
RECONSIDERING APPROPRIATE DOFETILIDE DOSING IN WOMEN
2015
-
RESPONSE TO EXERCISE TRAINING AND OUTCOMES IN HEART FAILURE PATIENTS WITH DIABETES MELLITUS: INSIGHTS FROM HF-ACTION
2015
-
SERUM BICARBONATE IN ACUTE HEART FAILURE: RELATIONSHIP TO TREATMENT STRATEGIES AND CLINICAL OUTCOMES
2015
-
STATINS AND EXERCISE TRAINING RESPONSE IN HEART FAILURE PATIENTS: INSIGHTS FROM THE HF-ACTION TRIAL
2015
-
TEMPORAL TRENDS IN CARDIAC REHABILITATION REFERRAL AMONG PATIENTS HOSPITALIZED WITH HEART FAILURE: ANALYSIS FROM AMERICAN HEART ASSOCIATION GET WITH THE GUIDELINES-HEART FAILURE REGISTRY
2015
-
TEMPORAL TRENDS IN CARE AND OUTCOMES OF PATIENTS RECEIVING FIBRINOLYTIC THERAPY COMPARED TO PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN THE GET WITH THE GUIDELINES CORONARY ARTERY DISEASE (GWTG-CAD) REGISTRY
2015
-
THE METABOLIC SYNDROME, CORONARY ARTERY CALCIUM SCORE AND CARDIOVASCULAR RISK RECLASSIFICATION
2015
-
THE PROGNOSTIC SIGNIFICANCE OF POSITIVE ELECTROCARDIOGRAPHY FINDINGS WITH NORMAL EXERCISE ECHOCARDIOGRAPHY
2015
-
TRANSCATHETER AORTIC VALVE REPLACEMENT RESULTS IN SIGNIFICANT REVERSE REMODELING IN PATIENTS WITH LEFT VENTRICULAR DILATION: A REPORT FROM THE PARTNER I TRIAL
2015
-
TCT-522 Outcomes of Laser-Assisted Balloon Angioplasty versus Balloon Angioplasty Alone for Below Knee Peripheral Arterial Disease
2014
-
TCT-536 Trends In Revascularization For Patients With Lower Extremity Peripheral Artery Disease: The Impact of Medicare Coverage Determination
2014
-
TCT-545 Contemporary Safety and Effectiveness of Peripheral Endovascular Interventions and Lower Extremity Bypass Surgery in the Treatment of Symptomatic Peripheral Arterial Disease
2014
-
A CASE OF REVERSIBLE “EISENMENGER SYNDROME”
2014
-
BLEEDING IS ASSOCIATED WITH A GREATER MORTALITY HAZARD IN WOMEN COMPARED WITH MEN: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM REGISTRY
2014
-
CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF HOSPITALIZED HEART FAILURE PATIENTS STRATIFIED BY ETIOLOGIES OF NON-ISCHEMIC CARDIOMYOPATHY
2014
-
DOWNSTREAM CLINICAL IMPLICATIONS OF ABNORMAL STRESS CARDIAC MAGNETIC RESONANCE IMAGING BASED ON APPROPRIATE USE CRITERIA
2014
-
GALECTIN-3 IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: A RELAX SUBSTUDY
2014
-
IMPACT OF SEVERE DYSPNEA ON OUTCOMES AND HEALTH CARE COSTS IN PATIENTS HOSPITALIZED WITH HEART FAILURE
2014
-
INFERIOR VENA CAVA MEASUREMENT BY FOCUSED CARDIAC ULTRASOUND IN ACUTE DECOMPENSATED HEART FAILURE PREVENTS HOSPITAL READMISSIONS
2014
-
LATE CARDIAC ABNORMALITIES IN ADULT SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A CARDIAC MRI STUDY
2014
-
MAJOR ADVERSE CARDIAC EVENTS IN CHILDREN WITH WILLIAMS BEUREN SYNDROME UNDERGOING SURGERY: AN ANALYSIS OF THE SOCIETY OF THORACIC SURGEONS CONGENITAL HEART SURGERY DATABASE
2014
-
NON-CANONICAL ANGIOTENSIN II TYPE 1A RECEPTOR-MEDIATED, BETA-ARRESTIN2-DEPENDENT SIGNALING CONTRIBUTES TO THORACIC AORTIC ANEURYSM FORMATION IN A MURINE MODEL OF MARFAN SYNDROME
2014
-
OUTCOMES ASSOCIATED WITH SAME-DAY DISCHARGE AFTER ELECTIVE PLACEMENT OF A PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AMONG OLDER PATIENTS
2014
-
OUTCOMES OF LASER-ASSISTED BALLOON ANGIOPLASTY VERSUS BALLOON ANGIOPLASTY ALONE FOR BELOW KNEE PERIPHERAL ARTERIAL DISEASE
2014
-
PERMANENT PACEMAKER USE AND OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION
2014
-
POST-DISCHARGE MORTALITY AND READMISSION IN HEART FAILURE PATIENTS WITH PRESERVED, BORDERLINE, AND REDUCED LEFT VENTRICULAR EJECTION FRACTION
2014
-
RELIABLE EVALUATION OF DYSPNEA (RED-ROSE): A PROSPECTIVE ANCILLARY STUDY FROM THE RENAL OPTIMIZATION STRATEGIES EVALUATION IN ACUTE HEART FAILURE (ROSE-AHF) TRIAL
2014
-
SHORT- AND LONG-TERM REHOSPITALIZATION AND MORTALITY FOR HEART FAILURE IN FOUR RACIAL/ETHNIC POPULATIONS
2014
-
SOCIOECONOMIC STATUS, MARITAL STATUS AND OUTCOMES IN HEART FAILURE: FINDINGS FROM HF-ACTION
2014
-
TEMPORAL TRENDS IN EARLY FOLLOW-UP AFTER HOSPITALIZATION FOR HEART FAILURE: DATA FROM GET WITH THE GUIDELINES-HEART FAILURE
2014
-
THE USE OF DUAL ANTIPLATELET THERAPY AND PATIENT OUTCOMES IN THOSE UNDERGOING PCI IN THE ROCKET AF TRIAL
2014
-
THE WORST SYMPTOM VISUAL ANALOGUE SCALE: A PROSPECTIVE ANCILLARY STUDY FROM THE RENAL OPTIMIZATION STRATEGIES EVALUATION IN ACUTE HEART FAILURE (ROSE-AHF) TRIAL
2014
-
TYPE A AORTIC DISSECTION AT A DIAMETER <5.5 CENTIMETERS: DOES MODERATE ENLARGEMENT OF THE AORTIC ROOT CARRY GREATER RISK THAN MODERATE SUPRACORONARY ASCENDING AORTIC ENLARGEMENT?
2014
-
USE AND COMPARATIVE EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY AMONG PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION: DATA FROM THE NCDR® REGISTRY
2014
-
TCT-717 Emergent Cardiac Surgery During Transcatheter Aortic Valve Implantation (TAVI) - Insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry
2013
-
TCT-85 Ventricular and Atrial Remodeling after the Percutaneous MitraClip: 4 year Follow-up Data from the EVEREST II Randomized Controlled Trial
2013
-
COMPARATIVE EFFECTIVENESS OF ENDOVASCULAR OR SURGICAL REVASCULARIZATION IN PATIENTS WITH CRITICAL LIMB ISCHEMIA: A META-ANALYSIS
2013
-
APIXABAN IS EFFICACIOUS AND SAFE IN PATIENTS WITH ATRIAL FIBRILLATION USING CONCOMITANT AMIODARONE: AN ANALYSIS FROM THE ARISTOTLE TRIAL
2013
-
ARE LONG-TERM CONSEQUENCES OF PULMONIC REGURGITATION FROM VALVOTOMY SIMILAR TO TETRALOGY OF FALLOT?
2013
-
ASSOCIATION BETWEEN ANGINA AND OUTCOMES IN HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION: ANALYSIS FROM THE DUKE DATABANK FOR CARDIOVASCULAR DISEASE
2013
-
ASSOCIATION BETWEEN PLATELET AGGREGATION AND MENTAL STRESS INDUCED MYOCARDIAL ISCHEMIA: RESULTS FROM THE REMIT TRIAL
2013
-
C-REACTIVE PROTEIN IN ACUTE DECOMPENSATED HEART FAILURE: INSIGHTS FROM ASCEND-HF
2013
-
CARDIAC RESYNCHRONIZATION THERAPY IN THE ELDERLY
2013
-
CARDIAC STRUCTURE AND FUNCTION DIFFER BY ETIOLOGY IN LONGSTANDING PULMONIC REGURGITATION
2013
-
COMPARATIVE EFFECTIVENESS OF SUPERVISED EXERCISE, MEDICAL THERAPY, AND ENDOVASCULAR OR SURGICAL REVASCULARIZATION IN PATIENTS WITH INTERMITTENT CLAUDICATION: A META–ANALYSIS
2013
-
COMPARISON OF TRANSCATHETER AND SURGICAL AORTIC VALVE REPLACEMENT IN SEVERE AORTIC STENOSIS: A LONGITUDINAL STUDY OF ECHO PARAMETERS IN COHORT A OF THE PARTNER TRIAL
2013
-
CONFLICTING RESULTS BETWEEN RANDOMIZED TRIALS AND OBSERVATIONAL STUDIES ON THE IMPACT OF PROTON PUMP INHIBITORS ON CARDIOVASCULAR EVENTS
2013
-
DEVELOPING A RISK MODEL FOR IN-HOSPITAL ADVERSE OUTCOMES FOLLOWING ICD IMPLANTATION: RESULTS FROM THE NCDR ®
2013
-
EXTRA-CARDIAC VASCULAR DISEASE IS ASSOCIATED WITH WORSE FIVE-YEAR CLINICAL OUTCOMES BUT NOT WITH VEIN GRAFT FAILURE AFTER CORONARY ARTERY BYPASS GRAFT SURGERY: INSIGHTS FROM THE PREVENT-IV TRIAL
2013
-
FIBRINOLYTIC THERAPY USE AMONG STEMI PATIENTS TRANSFERRED TO A PRIMARY PCI HOSPITAL IN THE UNITED STATES: A REPORT FROM THE MISSION: LIFELINE PROGRAM
2013
-
HOSPITAL COSTS FOR PEDIATRIC HEART SURGERY VARY WIDELY ACROSS INSTITUTIONS
2013
-
HOSPITAL VARIATION IN PERIOPERATIVE INSULIN USE AND GLUCOSE CONTROL IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFT SURGERY
2013
-
HYPOTENSION IN ACUTE DECOMPENSATED HEART FAILURE: FINDINGS FROM ASCEND-HF
2013
-
IMPACT OF ATRIAL FIBRILLATION ON EXERCISE CAPACITY IN DIASTOLIC HEART FAILURE: A RELAX TRIAL ANCILLARY STUDY
2013
-
INFLUENCE OF CHRONIC KIDNEY DISEASE ON THE EFFICACY OF PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS: A META-ANALYSIS OF THREE RANDOMIZED TRIALS
2013
-
INFLUENCE OF URIC ACID LEVEL IN PATIENTS HOSPITALIZED FOR HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM THE EVEREST TRIAL
2013
-
METABOLITE FACTOR LEVELS VARY WITH AGE BUT RELATIONSHIPS OF FACTORS WITH OUTCOMES ARE CONSTANT ACROSS AGE
2013
-
MINERALOCORTICOID RECEPTOR ANTAGONISTS IN DIABETIC PATIENTS HOSPITALIZED WITH HEART FAILURE: INSIGHTS FROM THE EVEREST TRIAL
2013
-
MITOCHONDRIA-TARGETED ANTIOXIDANT AMELIORATES DIET-INDUCED DIABETES AND DIASTOLIC DYSFUNCTION
2013
-
NEIGHBORHOOD CHARACTERISTICS ASSOCIATED WITH HIGH INCIDENCE OF OUT-OF-HOSPITAL CARDIAC ARREST AND LOW RATES OF BYSTANDER-INITIATED CPR: IMPLICATIONS FOR COMMUNITY-BASED EDUCATION INTERVENTION
2013
-
NMR-BASED LIPOPROTEIN PARTICLE PROFILING IDENTIFIES NOVEL SIGNATURES FOR CARDIOVASCULAR DISEASE
2013
-
NOVEL APPLICATION OF ACOUSTIC RADIATION FORCE IMPULSE IMAGING IN TRANSTHORACIC ECHOCARDIOGRAPHY
2013
-
NT-PROBNP IN ACUTE DECOMPENSATED HEART FAILURE: FINDINGS FROM THE ASCEND-HF STUDY
2013
-
OUTCOME OF LUNG DISEASE-RELATED PULMONARY HYPERTENSION AND IMPACT OF PULMONARY VASOREACTIVITY
2013
-
OUTCOMES OF MEDICARE BENEFICIARIES WITH HEART FAILURE AND ATRIAL FIBRILLATION
2013
-
OUTCOMES OF TEMPORARY INTERRUPTIONS OF RIVAROXABAN OR WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ROCKET AF TRIAL
2013
-
PERIPHERAL ARTERIAL DISEASE TESTING PRIOR TO AMPUTATION IN MEDICARE PATIENTS
2013
-
POSTOPERATIVE GLUCOSE CONTROL FOLLOWING CORONARY ARTERY BYPASS GRAFT SURGERY: PREDICTORS AND CLINICAL OUTCOMES
2013
-
PREDICTORS OF IN-HOSPITAL SURVIVAL WITH MEDICAL MANAGEMENT FOR TYPE A ACUTE AORTIC DISSECTION: IMPLICATIONS FOR SUBOPTIMAL SURGICAL CANDIDATES
2013
-
PREDICTORS OF URINE OUTPUT AND THE EFFECTS OF NESIRITIDE IN ACUTE DECOMPENSATED HEART FAILURE: RESULTS FROM ASCEND-HF
2013
-
PREVALENCE, PREDICTORS AND EFFECTS OF NESIRITIDE ON CHANGES IN RENAL FUNCTION DURING HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE: RESULTS FROM ASCEND-HF
2013
-
PROGNOSTIC ROLE OF HEMOCONCENTRATION IN PATIENTS HOSPITALIZED FOR HEART FAILURE WITH REDUCED EJECTION FRACTION: AN ANALYSIS OF THE EVEREST TRIAL
2013
-
RELATIONSHIP BETWEEN EXERCISE TRAINING AND CHANGES IN BIOMARKERS OF MYOCARDIAL STRESS, INJURY AND INFLAMMATION IN PATIENTS WITH CHRONIC HEART FAILURE
2013
-
RESTING VENTRICULAR-VASCULAR FUNCTION AND EXERCISE CAPACITY IN DIASTOLIC HEART FAILURE (DHF): A RELAX TRIAL ANCILLARY STUDY
2013
-
ROUTINE CINE-CMR FOR PROSTHESIS ASSOCIATED MITRAL REGURGITATION: A MULTICENTER COMPARISON TO ECHOCARDIOGRAPHY
2013
-
SERUM MAGNESIUM LEVELS AND POSTDISCHARGE OUTCOMES IN PATIENTS HOSPITALIZED FOR HEART FAILURE: INSIGHTS FROM THE EVEREST TRIAL
2013
-
THE ASSOCIATION BETWEEN DRIVE TIME AND REPERFUSION THERAPY USE AMONG STEMI PATIENTS TRANSFERRED FROM A NON-PRIMARY PCI HOSPITAL: A REPORT FROM THE MISSION: LIFELINE PROGRAM
2013
-
TIME TO INTRAVENOUS THERAPY AND CLINICAL OUTCOMES IN OLDER PATIENTS PRESENTING WITH ACUTE DECOMPENSATED HEART FAILURE: AN ANALYSIS OF THE ADHERE REGISTRY EMERGENCY MODULE
2013
-
SUPERIORITY OF 2D MYOCARDIAL STRAIN IMAGING IN THE DETECTION OF LATE-ONSET TREATMENT RELATED CARDIAC TOXICITY IN ASYMPTOMATIC ADULT SURVIVORS OF CHILDHOOD CANCER
2012
-
A PERIPHERAL BLOOD GENE EXPRESSION SCORE FOR CORONARY ARTERY DISEASE IN NON-DIABETIC PATIENTS IDENTIFIES PATIENTS AT LOW RISK FOR MAJOR CARDIOVASCULAR EVENTS AND INTERVENTIONAL PROCEDURES IN THE NEXT 12 MONTHS
2012
-
ACUTE AND LONG-TERM OUTCOMES OF CORONARY STENTING IN WOMEN VERSUS MEN: RESULTS FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY (NCDR)® CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS)® COHORT
2012
-
ASSOCIATION BETWEEN ADMISSION HEMOGLOBIN LEVEL AND GUIDELINE-BASED THERAPY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: AN ANALYSIS FROM THE NCDR®
2012
-
CAN SELECTIVE PULMONARY VASODILATOR THERAPY BE USED TO TARGET PULMONIC REGURGITATION? RESULTS OF THE PINOT NOIR TRIAL
2012
-
CHARACTERIZING RENAL FUNCTION IN STANDARD AND EXTENDED CRITERIA CARDIAC TRANSPLANT PATIENTS: A 10-YEAR EXPERIENCE
2012
-
COMPARISON OF SYMPTOMS AND QUALITY OF LIFE IN ATRIAL FIBRILLATION: RESULTS FROM THE ORBIT-AF REGISTRY
2012
-
DAMAGE TO POLYMER SURFACE AND DETACHMENT OF POLYMER FRAGMENTS DURING DELIVERY BALLOON EXPANSION OF DRUG-ELUTING STENTS: A PREVIOUSLY UNRECOGNIZED SOURCE FOR ADVERSE OUTCOMES
2012
-
DIABETIC PATIENTS HAVE SIMILAR VEIN GRAFT FAILURE AT 1 YEAR, BUT HIGHER 5-YEAR MORTALITY THAN NON-DIABETIC PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY: INSIGHTS FROM THE PREVENT-IV TRIAL
2012
-
DO COUNTRIES OR HOSPITALS WITH LONGER STAYS HAVE LOWER READMISSION RATES? FINDINGS FROM THE ASCEND-HF TRIAL
2012
-
DO EXTREME RISK CASES IMPACT HOSPITALS' RISK-ADJUSTED PCI MORTALITY RATINGS? RESULTS FROM THE NCDR®
2012
-
DOES PATIENT SELECTION MAKE THE CLOSURE STUDY LESS APPLICABLE?
2012
-
EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO CHADS2 AND HASBLED RISK SCORES FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
2012
-
GENDER DIFFERENCES IN BASELINE CHARACTERISTICS, QUALITY OF CARE MEASURES, AND OUTCOMES AMONG PATIENTS HOSPITALIZED WITH ACUTE DECOMPENSATED HEART FAILURE IN ASIA-PACIFIC AND LATIN AMERICA REGIONS: ANALYSIS OF THE ACUTE DECOMPENSATED HEART FAILURE INTERNATIONAL REGISTRY (ADHERE-INTERNATIONAL)
2012
-
GEOGRAPHIC VARIATION OF LOWER EXTREMITY AMPUTATION IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: RESULTS FROM U.S. MEDICARE 2000-2008
2012
-
INTERACTION BETWEEN ST2 LEVELS AND EXERCISE TRAINING IN PATIENTS WITH CHRONIC HEART FAILURE: ANALYSIS FROM THE HF-ACTION TRIAL
2012
-
LEVOSIMENDAN REDUCES MORTALITY IN PATIENTS WITH REDUCED EJECTION FRACTION UNDERGOING CARDIAC SURGERY: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
2012
-
LONG-TERM SAFETY AND EFFECTIVENESS OF STENTLESS PORCINE VERSUS STENTED PERICARDIAL BIOPROSTHESES IN OLDER PATIENTS UNDERGOING AORTIC VALVE REPLACEMENT: RESULTS FROM THE SOCIETY OF THORACIC SURGEONS (STS) ADULT CARDIAC SURGERY NATIONAL DATABASE
2012
-
LONG-TERM SURVIVAL FOLLOWING AORTIC VALVE REPLACEMENT AMONG HIGH-RISK ELDERLY PATIENTS IN THE UNITED STATES: INSIGHTS FROM THE STS ADULT CARDIAC SURGERY DATABASE, 1991-2007
2012
-
MEDICATION NONADHERENCE AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY
2012
-
PATIENT AND TRIAL FACTORS ASSOCIATED WITH NONPARTICIPATION IN RANDOMIZED CONTROLLED CARDIOVASCULAR TRIALS
2012
-
QUALITY OF LIFE 60 DAYS AFTER AN ACUTE HEART FAILURE EVENT: INSIGHTS FROM THE PROTECT TRIAL
2012
-
RESIDUAL SHUNT IN OPERATIVELY REPAIRED PATENT FORAMEN OVALE INCREASES PERIOPERATIVE MORBIDITY AND MORTALITY
2012
-
SELECTIVE PULMONARY VASODILATATION IMPROVES LEFT VENTRICULAR-RIGHT VENTRICULAR COUPLING IN PATIENTS WITH SIGNIFICANT PULMONARY VALVE REGURGITATION
2012
-
SIMULTANEOUS ANALYSIS OF MULTIPLE PROTEIN BIOMARKERS IDENTIFIES INDEPENDENT MARKERS OF LONG-TERM RISK FOR DEATH OR MYOCARDIAL INFARCTION
2012
-
SLOW GAIT AMONG OLDER ADULTS POST-AMI AND RISK FOR HOSPITAL READMISSION
2012
-
THE ASSOCIATION BETWEEN ANTICOAGULATION AND LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION: FINDINGS FROM THE ADHERE REGISTRY
2012
-
THE ASSOCIATION OF BETA-BLOCKER USE AND SELECTIVITY WITH OUTCOMES IN HEART FAILURE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FINDINGS FROM THE ORGANIZED PROGRAM TO INITIATE LIFE-SAVING TREATMENT IN HOSPITALIZED PATIENTS WITH HEART FAILURE
2012
-
THE ROLE OF ANTI-RO/SSA ANTIBODY LEVEL IN CONGENITAL HEART BLOCK AND POSSIBLE BENEFIT OF MATERNAL THERAPY WITH ANTI-INFLAMMATORY AGENTS
2012
-
TIMING OF ELECTROCARDIOGRAPHIC DIAGNOSIS IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH AN INITIAL NON-DIAGNOSTIC ELECTROCARDIOGRAM: AN OBSERVATIONAL ANALYSIS FROM THE NCDR®
2012
-
TRENDS IN LOWER EXTREMITY AMPUTATIONS IN PERIPHERAL ARTERY DISEASE PATIENTS: RESULTS FROM U.S. MEDICARE 2000-2008
2012
-
Diastolic Heart Failure - Innovative Extra and Intra Ventricular Solutions
2011
-
Evaluation of Dose Requirements for Prolonged Bivalirudin Administration in Patients with Renal Insufficiency and Suspected Heparin-Induced Thrombocytopenia
2011
-
One-Year Clinical Outcomes and Multivariate Predictors Following XIENCE V (R) Everolimus Eluting Coronary Stent System Implantation in Real-World Clinical Settings
2011
-
Post-Procedural ST-segment Deviation is an Independent Predictor of Long-Term Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-segment Elevation Myocardial Infarction
2011
-
Stent Thrombosis after Implantation of XIENCE V Everolimus-Eluting Coronary Stent Systems in On-label and Off-label Populations: Pooled Two-Year Results from Seven XIENCE V Coronary Stent Trials
2011
-
Stent Thrombosis and Dual Antiplatelet Interruption: Insights from the XIENCE V Everolimus-Eluting Coronary Stent System Trials
2011
-
The Impact of XIENCE V (R) Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients
2011
-
The Safety and Efficacy Of Cangrelor, a Short Acting, Intravenous, Reversible, Platelet P2Y12 Inhibiror In Patients Awaiting Cardiac Surgery: Results Of the BRIDGE Trial
2011
-
Utilization of Imaging Modalities Prior to Amputation Among Patients With Peripheral Arterial Disease or Diabetes - A Nationwide Study
2011
-
CARE AND OUTCOMES OF ASIAN ACUTE MYOCARDIAL INFARCTION PATIENTS: RESULTS FROM THE AMERICAN HEART ASSOCIATION GET WITH THE GUIDELINES-CORONARY ARTERY DISEASE PROGRAM
2011
-
CARE AND OUTCOMES OF HISPANICS ADMITTED WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION: FINDINGS FROM GET WITH THE GUIDELINES-HEART FAILURE
2011
-
5-YEAR FINAL RESULTS OF THE SISR (SIROLIMUS-ELUTING STENTS VERSUS VASCULAR BRACHYTHERAPY FOR IN-STENT RESTENOSIS) TRIAL
2011
-
ACUTE AND LONG-TERM OUTCOMES IN OLDER DIABETIC PATIENTS RECEIVING A CORONARY STENT: CONTEMPORARY RESULTS IN 405,679 PATIENTS
2011
-
ASSOCIATION OF SVCAM-1 WITH MAJOR ADVERSE CARDIAC EVENTS IN PATIENTS WITH STABLE CAD
2011
-
BILEAFLET MITRAL PROLAPSE MERITS OPERATION WITH LESS REGURGITATION THAN POSTERIOR LEAFLET PROLAPSE
2011
-
CHALLENGES IN THE TREATMENT OF NSTEMI PATIENTS AT HIGH RISK FOR BOTH ISCHEMIC AND BLEEDING EVENTS: INSIGHTS FROM THE ACTION REGISTRY-GWTG
2011
-
CHARACTERISTICS AND OUTCOMES OF PERCUTANEOUS REVASCULARIZATION OF UNPROTECTED LEFT MAIN CORONARY ARTERY STENOSIS IN THE UNITED STATES: RESULTS FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY, 2004-2008
2011
-
CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING THE XIENCE V® EVEROLIMUS-ELUTING STENT PRESENTING WITH CHRONIC KIDNEY DISEASE: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY
2011
-
COMPARISON OF TRENDS IN IN-HOSPITAL AND LONG-TERM OUTCOMES OVER TIME AMONG OLDER PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE CRUSADE QUALITY IMPROVEMENT REGISTRY
2011
-
CURRENT STATUS OF SMOKE-FREE AIR LAWS IN THE UNITED STATES
2011
-
DOES OBESITY AFFECT RESPONSE TO TREATMENT IN ACUTE DECOMPENSATED HEART FAILURE? A DIURETIC OPTIMIZATION STRATEGIES EVALUATION (DOSE) TRIAL SUBSTUDY
2011
-
EFFECT OF ADMISSION ORAL DIURETIC DOSE ON RESPONSE TO CONTINUOUS VERSUS BOLUS INTRAVENOUS DIURETICS IN ACUTE HEART FAILURE: AN ANALYSIS FROM DOSE-AHF
2011
-
EFFECT OF HEPARIN ADMINISTRATION ON METABOLOMIC PROFILES FROM SAMPLES OBTAINED DURING CARDIAC CATHETERIZATION
2011
-
EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF AN INVESTIGATIONAL ULTRA-SENSITIVE ASSAY FOR CARDIAC TROPONIN I
2011
-
HEMODYNAMIC EFFECTS OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN INOPERABLE AORTIC STENOSIS: ECHOCARDIOGRAPHIC RESULTS OF THE PARTNER STUDY
2011
-
HYPONATREMIA AND LONG-TERM OUTCOMES IN HEART FAILURE
2011
-
IMPACT OF POLYVASCULAR DISEASE ON LONG-TERM MORTALITY IN OLDER PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
2011
-
INCIDENTAL DETECTION OF LEFT VENTRICULAR THROMBUS BY ROUTINE ECHOCARDIOGRAPHY: INSIGHTS INTO PERFORMANCE CHARACTERISTICS USING DELAYED ENHANCEMENT (DE) CMR
2011
-
INTERNATIONAL VARIATION IN CARE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE: AN ANALYSIS OF THE ACUTE DECOMPENSATED HEART FAILURE NATIONAL REGISTRY UNITED STATES AND ACUTE DECOMPENSATED HEART FAILURE REGISTRY INTERNATIONAL
2011
-
LATE CARDIAC ABNORMALITIES AFTER ANTHRACYCLINE THERAPY IN ASYMPTOMATIC ADULT SURVIVORS OF CHILDHOOD CANCER: LONG-TERM FOLLOW-UP STUDY FROM THE MEMORIAL SLOAN-KETTERING CANCER CENTER
2011
-
LONG-TERM MORTALITY ASSOCIATED WITH MULTIVESSEL VERSUS CULPRIT VESSEL ONLY PERCUTANEOUS CORONARY INTERVENTION FOR PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM THE NATIONAL CARDIOVASCULAR CATHPCI DATA REGISTRY
2011
-
LONG-TERM SAFETY OF ANTITHROMBOTIC THERAPY IN NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH ATRIAL FIBRILLATION
2011
-
MARKERS OF CONGESTION, SYMPTOM RELIEF AND CLINICAL OUTCOMES AMONG PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE: DATA FROM THE DIURETIC OPTIMAL STRATEGY EVALUATION IN ACUTE HEART FAILURE STUDY
2011
-
OPTICAL COHERENCE TOMOGRAPHY ACCURATELY DETERMINES NEOINTIMAL COVERAGE AND STENT AREA OF BARE METAL AND DRUG-ELUTING CORONARY STENTS
2011
-
PATIENT AND PROVIDER FACTORS IN LIPID GOAL ATTAINMENT AFTER ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM THE TRANSLATIONAL RESEARCH INVESTIGATING UNDERLYING DISPARITIES IN ACUTE MYOCARDIAL INFARCTION PATIENTS' HEALTH STATUS (TRIUMPH) STUDY
2011
-
PATIENT RISK STATUS, CENTER VOLUME AND OUTCOME FOLLOWING THE NORWOOD OPERATION
2011
-
PERCUTANEOUS CORONARY INTERVENTION IN NATIVE ARTERIES VS. BYPASS GRAFTS IN PRIOR CORONARY BYPASS GRAFTING PATIENTS: A REPORT FROM THE CATHPCI REGISTRY®
2011
-
PREDICTION OF DEATH AND CONGESTIVE HEART FAILURE USING MULTIPLE CONCOMITANT ANGIOGRAPHIC BIOCHEMICAL AND ELECTROCARDIOGRAPHIC BIOMARKERS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION
2011
-
PREDICTORS OF CALCIFIC AORTIC STENOSIS: ROLE OF RACE/ETHNICITY
2011
-
PREDICTORS OF DEFECT-FREE COMPLIANCE WITH PROCESS MEASURES IN PATIENTS PRESENTING WITH ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM GET WITH THE GUIDELINES CAD
2011
-
PREVALENCE AND MORTALITY RISK ASSOCIATED WITH POST-OPERATIVE COMPLICATIONS FOLLOWING THE NORWOOD OPERATION: ANALYSIS OF A NATIONAL CLINICAL DATABASE
2011
-
QUALITY OF CARE AND OUTCOMES AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CHRONIC RENAL INSUFFICIENCY: REPORT FROM THE GET WITH THE GUIDELINES PROGRAM
2011
-
REFERRAL TO HOSPICE AND PREDICTED MORTALITY RISK AMONG PATIENTS HOSPITALIZED WITH HEART FAILURE: FINDINGS FROM GWTG-HF
2011
-
REGIONAL DIFFERENCES IN CLINICAL PROFILE, QUALITY OF CARE AND OUTCOMES AMONG HISPANIC PATIENTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION IN THE GET WITH GUIDELINES-CORONARY ARTERY DISEASE REGISTRY
2011
-
RISK ASSESSMENT FOR CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICES (LVAD): DOES THE DESTINATION THERAPY RISK SCORE WORK? AN ANALYSIS OF OVER 600 PATIENTS
2011
-
SERIOUS INFECTIONS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PCI ARE RARE, BUT ASSOCIATED WITH HIGHER MORTALITY
2011
-
THE LONG-TERM PROGNOSTIC IMPACT OF LOW HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN OLDER ADULTS WITH ACUTE MYOCARDIAL INFARCTION
2011
-
UNCONTROLLED HYPERTENSION AS A CONTRAINDICATION TO CARDIAC CATHETERIZATION: EVIDENCE TO SUPPORT GUIDELINES AND PRACTICE
2011
-
Clinical Outcomes In Real-World Patients with Long Lesions Receiving the XIENCE Everolimus-Eluting Stein (ILLS): One Year Results From the XIENCIV USA Study
2010
-
Consistent Efficacy and Safety of Everolimus-Eluting Stents In 5054 Patients From a Large Prospective Real World Study: One-Year Clinical Outcomes From the XIENCE V (R) USA Study
2010
-
EVEREST II Randomized Clinical Trial: A Critical Assessment of the Safely Data in Patients treated with the MitraClip
2010
-
Greater Ischemia Reduction and Associated Improved Survival with Revascularization Compared to Medical Therapy in Patients with Stable Corollary Artery Disease
2010
-
Low Clinical Event Rates In Real-World Patients with Acute :Myocardial Infarction Receiving XIENCE Everolinms-Eluting Stents: One-Year Results From the XIENCE V USA Study
2010
-
Low Clinical Event Rates in Real-World Patients Receiving the XIENCE V (R) Everolimus-Eluting Stent (EES) Via Direct Stenting: One-Year Results From the XIENCE V USA Study
2010
-
Net Adverse Clinical Events After Percutaneous Coronary Intervention in Patients Treated With Proton Pump inhibitors In Conjunction With Clopidogrel
2010
-
Prediction of Infarct Size by Magnetic Resonance Imaging Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
2010
-
Predictors of Stent Thrombosis In Real World Patients From XIENCE V (R) USA Study
2010
-
Temporal Trends in the Use of Thrombectomy During Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction in the United States
2010
-
The Impact of XIENCE NT Everolimus Eluting Stent on Health Status in On-Label and Off-Label Patients: One-Year Results from the XIENCE V USA Study
2010
-
The Impact of XIENCE V (R) Everolimus Elating Stent on health Status in Patients with Varying Degrees of Renal Function: Results from the XIENCE V USA Study
2010
-
EXERCISE TRAINING AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCKS IN PATIENTS WITH HEART FAILURE: RESULTS FROM HF-ACTION
2010
-
RISK FACTORS FOR RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH ISCHEMIC AND NONISCHEMIC CARDIOMYOPATHY FROM THE MADIT-CRT STUDY
2010
-
All-Cause Mortality Endpoint Comparison in Large Beta-Blocker Heart Failure Trials: United States (US) Versus Rest of World (ROW)
2009
-
Beta-Blocker Evaluation of Survival Trial (BEST) Findings Show Benefit of Bucindolol in Moderate to Severe HF Patients, According to Prespecified Statistical Analysis Plan
2009
-
Carotid Artery Stenting For Significant Carotid Stenosis in Patients With Contralateral Occlusion: The German ALKK CAS - Registry Experience
2009
-
Direct Presentation, Field-Referral, and Interhospital Transfer in a Network-Based System for Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Result in Similar 1-Year Mortality
2009
-
Frequency of Lipid Core Plaque as Determined by Near-Infrared Spectroscopy at Target Lesion Sites in Patients Undergoing PCI
2009
-
Immediate ST-Segment Resolution Is Associated With Left Ventricular Function and Infarct Size Measured by Cardiovascular Magnetic Resonance in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention
2009
-
J Point ST Elevation Does Not Predict Arrhythmic Events in Dilated Cardiomyopathy
2009
-
Near-Infrared Spectroscopic Detection of Lipid-Core Coronary Plaques Remote From the Target Lesion in Patients Undergoing PCI
2009
-
Predictors of Clinical Restenosis in Real-World Clinical Practice: An Analysis of Drug Eluting Stents in the EVENT Multicenter Registry
2009
-
Predictors of Guideline Adherence for Inpatient Heart Failure Care
2009
-
Randomized Comparison of Primary Percutaneous Coronary Intervention With Combined Proximal Embolic Protection and Thrombus Aspiration and Primary Percutaneous Coronary Intervention Alone in ST-segment Elevation Myocardial Infarction
2009
-
Use of Pulsed Electromagnetic Fields For Ischemic Cardiomyopathy Therapy (EFFECT Trial): A Randomized, Double-Blind, Parallel, Placebo-Controlled, Prospective Trial
2009
-
How Should Dyspnea Be Measured in Acute Heart Failure?: A Comparison of Visual Analog and Likert Scales in an International Clinical Trial
2009
-
PFO Morphology in Young and Older Patients With Cryptogenic Stroke on Transesophageal Echocardiography
2009
-
Use of Balloon Aortic Valvuloplasty to Size the Aortic Annulus Prior to Implantation of a Balloon Expandable Transcatheter Heart Valve
2009
-
Abnormal myocardial SPECT is a powerful predictor of cardiac death (CD) in patients with chronic kidney disease (CKD)
2008
-
Are guideline recommended therapies being applied to elderly patients hospitalized with heart failure?
2008
-
Bleeding and ischemic events run parallel in NSTEMI patients
2008
-
Bone marrow progenitor cell stores impact circulating EPC levels and are depleted in elderly subjects
2008
-
Clopidogrel and CABG-related bleeding: Not as important as currently believed?
2008
-
Comparison of stress CMR with stress SPECT for the diagnosis of coronary artery disease
2008
-
Contemporary predictors of procedural mortality among patients undergoing percutaneous coronary intervention (PCI): Results from the ACC-NCDR
2008
-
Continuous flow left ventricular assist device as a bridge to cardiac transplantation: Long-term outcomes
2008
-
Deadly quartet of clinical factors among patients with diabetes mellitus undergoing saphenous vein graft interventions
2008
-
Decline in the use of drug-eluting stents for patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Results from the CRUSADE and ACTION registries
2008
-
Discordance between patient-predicted and model-predicted life expectancy among outpatient heart failure patients
2008
-
Do selected markers of inflammatory response during the acute phase of ST-segment elevation myocardial infarction relate to outcome?
2008
-
Evaluation of mechanical dyssynchrony using phase analysis of gated SPECT Imaging in patients with mild-moderate left ventricular dysfunction
2008
-
Expression profiling of peripheral blood cells identifies genes that distinguish patients with and without coronary artery stenosis
2008
-
Factors related to heart rupture in acute coronary syndromes. The global registry of acute coronary events
2008
-
Impact of changes in brain natriuretic peptide levels on survival in outpatients with pulmonary hypertension
2008
-
Impact of stress SPECT imaging after revascularization: Evaluating the appropriateness criteria
2008
-
Incidence and bleeding outcomes of excess unfractionated heparin dosing among patients with ST-Segment elevation myocardial infarction undergoing fibrinolysis
2008
-
Incidence and impact of acquired thrombocytopenia among patients with acute coronary syndromes
2008
-
Incidence and management of acquired thrombocytopenia among patients receiving prolonged heparin venous thromboembolism prophylaxis: Insights from the complications after thrombocytopenia caused by heparin (CATCH) registry
2008
-
Influence of body mass index on revascularization decisions and outcomes in patients with coronary artery disease: a 15-year experience from the Duke Databank
2008
-
New onset atrial fibrillation following myocardial infarction is a strong independent predictor of mortality in patients treated with primary percutaneous coronary intervention
2008
-
Overlapping drug-eluting stents: Intravascular ultrasound insights from cobalt chromium stent with antiproliferative for restenosis II (COSTAR II) trial
2008
-
Pre-hospital electrocardiograms: Potential answer to the time to reperfusion challenge
2008
-
Predictors of sudden cardiac death change with time after myocardial infarction: Results from the VALIANT Trial
2008
-
Prevalence and in-hospital outcomes of multivessel PCI during primary PCI for ST-segment elevation myocardial infarction: Results from the American college of cardiology national cardiovascular data registry (ACC-NCDR)
2008
-
Prevalence and prognostic significance of pre-procedure cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: Results from the EVENT registry
2008
-
Relationship between left ventricular dyssynchrony and functional capacity in moderate to severe heart failure: the HF-ACTION trial nuclear ancillary study
2008
-
Relationships among the Kansas City cardiomyopathy questionnaire and clinical measures in patients with heart failure
2008
-
Representation of women in randomized clinical trials of cardiovascular disease prevention
2008
-
Sex differences in clinical presentation and angiographic data in acute coronary syndromes
2008
-
Sex, age and outcome of non-ST elevation acute coronary syndrome: An analysis of the CRUSADE initiative
2008
-
Sex-based differences in mortality following acute coronary syndromes
2008
-
The CRUSADE bleeding score to assess baseline risk of major bleeding in non-ST-segment elevation myocardial infarction
2008
-
Trends in care disparities for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1994 to 2006
2008
-
Understanding clinical factors associated with the lack of use of internal mammary artery conduit in patients undergoing coronary artery bypass surgery
2008
-
Underuse of left ventricular function assessment in patients with newly diagnosed heart failure
2008
-
Utility of multi-detector computed tomography (MDCT) as a diagnostic triage tool for patients presenting with chest pain to the emergency department: A meta-analysis
2008
-
PERCUTANEOUS AORTIC VALVES: Predicting appropriate size
2008
-
A gender and racial gap in implantable cardioverter defibrillator use among hospitalized heart failure patients: Data from the American Heart Association's get with the guidelines heart failure (GWTG-HF) program.
2007
-
ALOX5AP genetic variants are associated with in-stent restenosis after percutaneous coronary intervention
2007
-
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin
2007
-
Age at bidirectional glenn procedure and mortality: A multi-center, international registry
2007
-
Are there any differences in the clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass surgery?
2007
-
Bleeding complications are a major driver of resource use among patients with acute coronary syndromes
2007
-
Bleeding is common among patients treated with heparin experiencing thrombocyllopenia and confers a high mortality risk: Report from the CATCH registry
2007
-
Blood pressure control with clevidipine compared to nitroglycerin in the treatment of perioperative hypertension: Primary results from the randomized ECLIPSE trial
2007
-
Blood transfusion is independently associated with death in acute myocardial infarction: Insights from APEX-AMI (Assessment of Pexelizumab in Acute Myocardial Infarction) trial
2007
-
Carotid stenting in patients with prior carotid endarterectomy is associated with favorable outcomes in community practice: Insights from the large German multicenter ALKK CAS - Registry.
2007
-
Clinical predictors of presence of left main coronary artery disease on angiography in a large cohort
2007
-
Continuation of warfarin at hospital discharge in patients with acute coronary syndromes on chronic warfarin anticoagulation
2007
-
Disruption of the Smad3 signaling pathway attenuates post-infarction remodeling
2007
-
Echocardiography provides important prognostic information in patients with advanced pulmonary hypertension, even after initiation of vasodilator therapy
2007
-
Failure to prescribe beta-blockers in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction: Results from the international VALIANT registry
2007
-
Faster times to primary percutaneous coronary intervention are associated with better survival: Insights from the APEX-AMI (Assessment of Pexelizumab in Acute Myocardial Infraction) trial
2007
-
High-dose atorvastatin - Better value for money: the treating to new targets trial US economic substudy in 5,308 stable coronary heart disease patients
2007
-
Human cord blood endothelial progenitors decrease neointimal hyperplasia in SCID mouse vein grafts
2007
-
Impact of hospital performance on underuse of therapies, among patients with chronic kidney disease and non-ST-segment elevation acute coronary syndromes
2007
-
Implantable cardioverter defibrillator therapy improves the survival of patients with prior coronary revascularization: Data from the sudden cardiac death in heart failure trial
2007
-
Increased bleeding risk among Asians with non-ST-segment elevation acute coronary syndromes: Insights from the CRUSADE quality improvement initiative
2007
-
Inhibition of 8 delta-protein kinase C to ameliorate reperfusion injury during primary percutaneous coronary intervention for acute ST-elevation myocardial infarction - Preliminary results from the DELTA MI trial
2007
-
Initial aspirin dose for the treatment of ST elevation myocardial infarction
2007
-
Is rhythm control superior to rate control in patients with atrial fibrillation and diastolic heart failure?
2007
-
Left ventricular end diastolic pressure is a predictor of suboptimal myocardial reperfusion in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction
2007
-
Less is better, none is best: Angina and health related quality of life
2007
-
Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program
2007
-
Long-term intravenous and subcutaneous prostaglandin therapy outperforms oral enclothelln antagonism in patients with eisenmenger syndrome
2007
-
Low congestion score one month after hospitalization predicts better function and survival
2007
-
Metabolic syndrome as a predictor of restenosis in diabetic patients presenting with acute coronary syndrome or angina
2007
-
Non-ST-segment elevation acute coronary syndrome patients on chronic warfarin anticoagulation: Care and outcomes
2007
-
Patients transferred for primary PCI in APEX-AMI (Assessment of pexelizumab in acute myocardial infarction) trial have only modest symptom onset to PCI delays and good outcomes
2007
-
Patterns of HDL levels in patients with non-ST-segment elevation acute coronary syndromes and association with clinical outcomes
2007
-
Predictors of persistent angina among coronary disease patients
2007
-
Red cell distribution width as a novel prognostic marker in heart failure: Data from the CHARM program and the duke databank
2007
-
Reperfusion "BURST" arrhythmias as a biomarker of myocellular damage despite TIMI 3 epicardial flow
2007
-
The quality of care for patients hospitalized with ischemic verses nonischemic heart failure in the American heart association's get with the guidelines (GWTG-HF) program
2007
-
The utility of measuring heart rate recovery after exercise testing to risk stratify adults with congenital heart disease
2007
-
Time is muscle: Delay in primary PCI results in larger infarct size by delayed enhancement cardiac magnetic resonance - Results from the APEX-AMI study.
2007
-
Trends in the treatment and outcomes of patients with non-ST-segment elevation acute coronary syndromes managed medically without cardiac catheterization
2007
-
Use and outcomes of acute clopiclogrel therapy in non-ST-segment elevation myocardial infarction in community practice: Results from CRUSADE
2007
-
Variants in genes associated with inflammation and vascular cell function are associated with vulnerable plaque
2007
-
Ventricular arrhythmia "bursts" in the setting of acute anterior infarct artery recanalization: A re-definition of "reperfusion arrhythmias"
2007
-
Warm-dry clinical profile at 1 month after heart failure hospitalization can be used for triage in advanced heart failure: An analysis from the evaluation study of CHF and pulmonary artery catheterization effectiveness (ESCAPE) trial
2007
-
What is the best measure for rewarding quality of care: Defect-free vs. composite scoring? An analysis from the American heart association's get with the guidelines-coronary artery disease (GWTG-CAD) program?
2007
-
Can morphology on transesophageal echocardiography differentiate an asymptomatic from symptomatic patent foramen ovale?
2007
-
ACC/AHA performance measures for patients hospitalized with HF: Are they predictive of clinical outcomes?
2006
-
Acute heart failure asociated with atrial fibrillation: A distinct disorder and not just a fast pulse rate?
2006
-
Cardiac resynchronization device placement during hospitalization for heart failure is associated with a significant improvement in early clinical outcomes
2006
-
Clinical and angiographic correlates of long-term mortality following percutaneous intervention of saphenous vein graft
2006
-
Do hospitals that provide heart failure patient education prior to discharge also promote continuity of care? - A report from OPTIMIZE-HF
2006
-
Echocardiographic risk-stratification for early surgery in patients with endocarditis is a cost-attractive alternative to standard care
2006
-
Enoxaparin dosing and bleeding in real world practice: Results from CRUSADE
2006
-
Incidence and not timing of death or myocardial infarction differ according to risk in patients with non-ST elevation acute coronary syndromes: Implications for long-term treatment and follow-up
2006
-
Initial heart rate and systolic blood pressure provides important insights in the risk-stratification of agerelated mortality among patients presenting with cardiogenic shock and acute ST-elevation myocardial infarction treated with fibrinolysis
2006
-
Patterns of brain natriuretic peptide utilization for risk stratification of patients with non-ST-segment elevation acute coronary syndromes
2006
-
Percutaneous coronary intervention in patients receiving only a single subcutaneous dose of enoxaparin: Results from the SYNERGY trial
2006
-
Pregnancy complications as risk factors for cardiac and all-cause mortality
2006
-
Pregnancy complications as risk factors for coronary artery disease
2006
-
Prolonged heparin exposure, development of thrombocytopenia, use of GP IIb/IIIa inhibitors, and history of renal dysfunction predict moderate or severe bleeding: A report from the complications after thrombocytopenia caused by heparin (CATCH) registry
2006
-
Pulmonary hypertension with excessive transpulmonary gradients among mitral stenotics: Prevalence and clinical outcome following percutaneous balloon mitral commissurotomy
2006
-
Rhythm versus rate control for atrial fibrillation in post-Ml patients with heart failure: Results from the VALIANT trial
2006
-
Sex-related differences in non-obstructive coronary artery disease among patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE quality improvement initiative
2006
-
Sudden cardiac death risk prediction is enhanced when clinical characteristics and left ventricular ejection fraction are evaluated together rather than relying on left ventricular ejection fraction alone
2006
-
The association between hospital guideline adherence, dosing safety, and patient outcomes: Results from the CRUSADE quality improvement initiative
2006
-
The influence of myocardial fibrosis by delayed enhanced MRI on left ventricular diastolic function in hypertrophic cardiomyopathy
2006
-
Use of percutaneous coronary intervention versus coronary artery bypass surgery for patients with acute coronary syndromes and multivessel coronary disease in the drug-eluting stent era: Data from the CRUSADE quality improvement initiative
2006
-
Which patients with previous bypass surgery benefit most from repeat revascularization?
2006
-
Impedance cardiography as a predictor of clinical outcome in heart failure patients
2006
-
Adjunctive abciximab to reperfusion therapy in patients with acute st-segment elevation myocardial infarction: A meta-analysis of randomized trials
2005
-
Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients
2005
-
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction. Results from the CADILLAC trial.
2005
-
Comparison of echocardiographic predictors of clinical events in patients with predominantly systolic or diastolic dysfunction
2005
-
Efficacy of gadoversetamide enhanced MRI for the diagnosis and assessment of myocardial infarction: An international, multicenter, double-masked, randomized, phase 2 trial
2005
-
Even short-duration exercise training improves brain natiuretic peptide and C-reactive protein levels in severely deconditioned patients with coronary disease
2005
-
Gene expression profile in circulating leukocytes identifies patients with coronary artery disease
2005
-
High mortality after discharge among patients with high risk for developing heparin-induced thrombocytopenia or thrombosis: 6-month follow-up results of the complications after thrombocytopenia caused by heparin (CATCH) registry
2005
-
Lack of improvement in quality of life post-hospitalization predicts mortality in patients with advanced heart failure
2005
-
Long-term prognosis of patients with CHF associated with depression
2005
-
Meta-analysis of survival and angina relief after transmyocardial revascularization
2005
-
Natriuretic peptide insights in acute myocardial infarction
2005
-
Prediction of mortality following primary percutaneous coronary intervention for acute myocardial infarction: The CADILLAC risk score
2005
-
Prediction of rehospitalization and death in advanced heart failure patients by nurses and physicians
2005
-
Rapid assay B-type natriuretic peptide (BINP) predicts outcomes and hemodynamics in patients hospitalized with decompensated heart failure
2005
-
Short-term outcomes of atrial fibrillation complicating coronary artery bypass graft surgery: Results from the PREVENT-IV trial
2005
-
Spironolactone, diuretics or none in ischemic heart failure: Use and outcomes from the Duke Databank
2005
-
Statin therapy is critical in heart failure patients who meet national cholesterol education panel high risk criteria
2005
-
Stroke after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial
2005
-
The baseline ECG in ST elevation myocardial infarction provides powerful prognostic insight: Observations from ASSENT
2005
-
The relation between angina, treatment and quality of life in cardiac patients
2005
-
The use and effect of surgical therapy for prosthetic valve infective endocarditis: A propensity analysis of a multicenter, international cohort
2005
-
What definition of vasoreactivity to inhaled nitric oxide best predicts mortality risk in patients with pulmonary hypertension?
2005
-
Myocardial scar morphology as determined by magnetic resonance imaging identifies substrate for ventricular tachycardia
2005
-
A randomized controlled trial of Internet-based academic detailing in heart failure: Failure to engage or change
2004
-
Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy
2004
-
Cardiac histopathologic changes in young military recruits experiencing sudden death due to anomalous coronary origin compared with obstructive coronary artery disease
2004
-
1001-2 Is the “hub-and-spoke” model working? Patterns of transfer for high-risk acute coronary syndromes patients from community hospitals without revascularization capacity
2004
-
1002-82 Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction: The obesity paradox
2004
-
1003-93 Outcomes prediction with continuous 12-lead ST-segment recovery in ST elevation myocardial infarction: Similarities or differences with thrombolytic versus direct stenting populations?
2004
-
1012-104 Safety of beta-blockers in patients with heart failure and renal insufficiency: Data from IMPACT-HF
2004
-
1033-109 Assessing the need for repeat baseline exercise tests in heart failure patients: Early experience from HF-ACTION
2004
-
1040-69 The effect of state mandated continuing medical education on the use of proven therapies in patients with an acute myocardial infarction
2004
-
1042-82 White blood cell count predicts higher risk of intermediate-term outcomes in patients stabilized after acute coronary syndromes: Observations from the SYMPHONY and 2ndSYMPHONY trials
2004
-
1056-163 Duke viability index predicts long-term mortality in patients with ischemic cardiomyopathy independent of treatment allocation
2004
-
1061-100 Predictors of reinfarction after ST elevation myocardial infarction and glycoprotein receptor blockade: Analysis from the CADILLAC trial
2004
-
1077-71 The association between care and outcomes in patients with acute coronary syndrome: National results from CRUSADE
2004
-
1077-76 Holiday heart: Decreased use of evidence-based therapies in patients with acute myocardial infarction admitted during holiday weeks
2004
-
1085-167 Dose-response study of the efficacy and safety of fosinopril in children with hypertension: A randomized, double-blind, placebo-controlled, multicenter clinical trial
2004
-
1096-71 A national survey of health care practitioners' knowledge of the QT interval
2004
-
1097-94 Early versus delayed intervention in non-ST-elevation acute coronary syndromes: A natural experiment from the CRUSADE initiative
2004
-
1108-120 A gap in care: Heart failure patients undergoing major noncardiac surgery
2004
-
1114-205 Racial differences in blood pressure response in children with hypertension treated with fosinopril
2004
-
1118-102 Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction: Results from the CARDINAL trial
2004
-
1123-180 Incidence and evaluation of heparin-induced thrombocytopenia (HIT) among patients treated with prolonged heparin and among thrombocytopenic patients in the cardiac care unit: Preliminary results of the CATCH registry
2004
-
1123-185 Is there regional variation in levels of serum brain natriuretic peptide in patients with pulmonary hypertension?
2004
-
1126-110 Predicting significant coronary artery disease in heart failure patients
2004
-
1135-72 Higher mortality and less evidence-based therapies among medicaid-insured patients with high-risk acute coronary syndromes: Results from CRUSADE
2004
-
1143-135 The risk of prosthetic valve endocarditis in patients with staphylococcus aureus bacteremia
2004
-
1143-136 Prosthetic valve endocarditis: Report of 214 cases from the intracardiac echocardiography prospective cohort study
2004
-
1153-74 Physician counseling can influence health-related quality of life
2004
-
1154-90 Suboptimal treatment of patients with non-ST elevation acute coronary syndromes presenting with positive baseline troponin values
2004
-
1169-152 Clinical evaluation of patients with suspected coronary artery disease using a multimodality stress magnetic resonance imaging protocol
2004
-
1171-206 Frequency of infective endocarditis among infants and children with staphylococcus aureus bacteremia
2004
-
801-3 Anemia worsens prognosis after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial
2004
-
836-2 Diagnostic utility of contrast enhanced magnetic resonance imaging for screening patients at risk for sudden cardiac death
2004
-
836-5 Comprehensive stress magnetic resonance imaging compared to stress echo in the evaluation of patients presenting to the emergency department with chest pain
2004
-
838-4 National evaluation of long-term adherence to beta-blocker therapy after acute myocardial infarction in patients with commercial health insurance
2004
-
840-1 Myocardial fibrosis patterns correlate with adverse right ventricular morphology and function in patients with repaired conotruncal heart defects
2004
-
868-2 Cardiovascular risk factors and outcomes in patients with definite endocarditis: The international collaboration on endocarditis - prospective cohort study
2004
-
869-2 Impact of intravenous beta-blockade during primary percutaneous intervention on convalescent left ventricular function
2004
-
869-4 Sex disparities in the treatment of non-ST-segment elevation acute coronary syndromes
2004
-
884-3 Clinical implications of discordant creatine kinase-MB and troponin results in patients with acute coronary syndromes
2004
-
Abciximab readministration: Final results of the Reopro(fi) read ministration registry
2003
-
Aggressive treatment aimed at raising high-density lipoprotein cholesterol in stable patients with angiographically evident coronary disease prevents stenosis progression and reduces cardiovascular events
2003
-
Are patients properly informed prior to revascularization decisions?
2003
-
Are the results of the Multicenter Automatic Defibrillator Implantation Trial-II applicable to patients seen at a tertiary referral center?
2003
-
Baseline features and clinical results in patients excluded from randomization from a large international trial of reperfusion strategies in acute myocardial infarction: The CADILLAC registry
2003
-
Benefits and risks of abciximab use in primary Angioplasty for acute myocardial infarction: The CADILLAC trial
2003
-
Converting patients intolerant of simvastatin to atorvastatin is a safe practice and associated with significant improvement in lipid control and less creatine kinase elevation
2003
-
Degree of baseline risk should, but does not, influence treatment decisions in non-ST elevation acute coronary syndromes: Evidence from international clinical trials
2003
-
Differing clinical characteristics among black and white patients referred for treatment of pulmonary hypertension
2003
-
Early predictors of mortality in patients with endocarditis
2003
-
Economic burden of nonischemic congestive heart failure: Evidence from PRAISE-2
2003
-
Elderly patients have better functioning, less angina at one year with coronary artery bypass graft
2003
-
Elevated troponin I predicts clinical events in patients admitted with acute heart failure: Insights from the RITZ-4 trial
2003
-
Enoxaparin is superior to unfractionated heparin after fibrinolysis in acute myocardial infarction: Meta-analysis of ASSENT-3, HART-II, and ENTIRE-TIMI-23 trials
2003
-
Evaluation of platelets in heart failure: Is platelet activity related to etiology, functional class, or clinical outcomes?
2003
-
Holter monitoring and treadmill testing assist in prediction of future events in patients with classic mitral valve prolapse
2003
-
Home health care for coronary artery disease patients impacts quality of life
2003
-
How important is time to treatment with primary percutaneous coronary intervention for acute myocardial infarction? Results from the CADILLAC trial
2003
-
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: A systematic overview of randomized clinical trials
2003
-
Influence of guidelines and results from major clinical trials on medical practice: Findings from the global registry of acute coronary events (GRACE)
2003
-
Long-term adherence to evidence-based therapies for coronary artery disease and heart failure in the outpatient setting
2003
-
Magnitude and impact of after hours treatment delay in patients undergoing primary Angioplasty for acute myocardial infarction: The CADILLAC trial
2003
-
Marked mortality risk of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction
2003
-
Moderate obesity is associated with better intermediate-term survival in acute coronary syndromes: Results from the SYMPHONY and 2nd SYMPHONY clinical trials
2003
-
Myocardial viability predicts long-term survival for patients with severe left ventricular dysfunction
2003
-
Opening the window of facilitated percutaneous coronary intervention in acute infarction: The role of combined IIb/IIIa inhibition and thrombolytic therapy
2003
-
Outcomes in patients requiring bail-out abciximab during primary intervention in acute myocardial infarction: Analysis from the CADILLAC trial
2003
-
Patient, hospital, physician, and market correlates of one-year costs after acute myocardial infarction in the elderly
2003
-
Predictors and long-term mortality of atrioventricular block after acute myocardial infarction treated with thrombolysis
2003
-
Predictors and sequelae of subacute thrombosis after percutaneous intervention in acute myocardial infarction: The CADILLAC trial
2003
-
Predictors of treatment delay in patients with acute myocardial infarction undergoing primary angioplasty: An analysis from the CADILLAC trial
2003
-
Prognostic value of the absolute degree of ST-segment elevation of the ECG at baseline and after primary angioplasty: Analysis from the CADILLAC trial
2003
-
Recurrence of ST elevation after early reperfusion as a marker of prognosis in ST elevation infarction
2003
-
Relationship between time to treatment, electrocardiographic ST-segment resolution, and outcomes with primary percutaneous coronary intervention for acute myocardial infarction: Results from the CADILLAC trial
2003
-
ST-segment elevation resolution as a predictor of mortality in patients with thrombolysis in myocardial infarction III flow in the infarct artery after primary angioplasty: The CADILLAC trial
2003
-
Safety of adjunctive glycoprotein IIb/IIIa blockade during rescue/early percutaneous coronary intervention following full-dose fibrinolytic therapy for acute myocardial infarction
2003
-
Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial
2003
-
The impact of implanting card ioverter-defibrillators in patients who meet the multicenter automatic defibrillator implantation trial-II criteria on the health care system at a tertiary referral center
2003
-
Transmural action potential repolarization heterogeneity develops postnatally in the rabbit
2003
-
Determination of infarct size by contrast-enhanced MRI: Comparison between quantitative planimetry and a semiquantitative visual score method
2003
-
Are racial differences in the long-term prognosis of systolic heart failure independent of differences in etiology?
2002
-
Continuing evolution of treatment strategy and outcome for coronary artery disease: Observational data 1986-2000
2002
-
Does an educational intervention influence patient decision making? Impact of an interactive video on ischemic heart disease patients
2002
-
Dual-site or bi-atrial pacing does not enhance atrial activation as compared to pacing from novel single right atrial sites in humans
2002
-
Predictors of warfarin use in atrial fibrillation: Insights from the FRACTAL Registry
2002
-
Predicting survival from the coronary arteriogram: an experience-based statistical index of coronary artery disease severity
2002
-
By what mechanism does glucose-insulin-potassium improve survival following myocardial infarction?
2001
-
Conivaptan (CI-1025, YM087), a combined vasopressin V-1A/V-2 receptor antagonist, reduces pulmonary capillary wedge pressure independent of baseline serum sodium or vasopressin levels in heart failure patients
2001
-
Decreased contractile reserve in severe aortic insufficiency using MRI-derived stress and strain relationships
2001
-
Alternate atrial pacing sites shorten atrial activation time in humans
2000
-
Hospital characteristics and treatment of acute myocardial infarction: Role of ownership and teaching status
2000
-
Noninvasive, quantitative detection of left ventricular wall dysfunctional areas in patients with ischemic cardiomyopathy using magnetic resonance imaging with tissue tagging and finite element modeling
2000
-
Reperfusion therapy among paced patients with acute myocardial infarction
2000
-
Treatment of paced patients with acute myocardial infarction
2000
-
An Experimental Model of Myocardial Hibernation
1998
-
Intermediate-term Results From Carpentier-Edwards Tricuspid Valve Repair
1998
-
Perioperative Morbidity and Mortality Following Transmyocardial Laser Revascularization
1998
-
Adenoviral-mediated gene therapy induces sustained intrapericardial vascular endothelial growth factor expression in dogs: Effect on myocardial angiogenesis
1997
-
Long-term survival after biological versus mechanical aortic valve replacement in 1156 patients
1997
-
Manual and semiautomated measurement of left ventricular volume using real-time, three dimensional echocardiography in vivo
1997
-
Pharmacodynamics of basic fibroblast growth factor: Effect of route of administration on regional distribution
1997
-
The pericardium as a repository for an angiogenic growth factor: Effect of intrapericardial basic fibroblast growth factor on myocardial collateral development
1997
-
EVALUATION OF MAMMARY ARTERY GRAFT PERFUSION USING CONTRAST ECHOCARDIOGRAPHY
1994
-
SUPERIOR ACUTE AND 6 MONTH RESULTS WITH FEWER COMPLICATIONS USING THE INOUE BALLOON TECHNIQUE FOR MITRAL COMMISSUROTOMY
1994
-
VENTRICULAR GEOMETRY IS ALTERED BY ACUTE CHANGES IN INOTROPIC STATE IN FAILING BUT NOT NORMAL HEARTS
1994
-
CRITICAL MASS AND THE SURGICAL-TREATMENT OF VENTRICULAR-FIBRILLATION - THE EFFECT OF RIGHT VENTRICULAR ISOLATION ON VENTRICULAR-FIBRILLATION THRESHOLDS
1984
-
CRYOSURGICAL DENERVATION OF THE HEART
1984
-
QUANTIFICATION OF REGIONAL MYOCARDIAL-FUNCTION AFTER ACUTE ISCHEMIC-INJURY
1984
-
QUANTITATIVE COMPARISON OF SEVERAL METHODS OF EXTERNAL CARDIAC MASSAGE
1984
-
THE ELECTRICAL STATUS OF THE HEART AS A DETERMINANT OF REINFUSION CARDIOPLEGIA FLOW DISTRIBUTION
1984
-
DIFFERENTIAL TRANSMURAL MYOCARDIAL ARREST USING HYPERKALEMIC AND NORMOKALEMIC CARDIOPLEGIC SOLUTIONS
1983
-
ELECTROPHYSIOLOGIC EFFECTS OF NIFEDIPINE CARDIOPLEGIA
1983